The Role of Caspase-7 during Infection with Listeria monocytogenes and during Intoxication with Listeriolysin O. by Cassidy, Sara Kathryn Bondi
The role of caspase-7 during infection with Listeria monocytogenes and during 




Sara Kathryn Bondi Cassidy 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Microbiology and Immunology) 


















 Associate Professor Mary X.D. O’Riordan, Chair  
 Professor Victor J. DiRita  
 Professor Colin S. Duckett 
 Professor Michele S. Swanson 
	   ii	  
Dedication 
 
This work is dedicated to my daughter, Rosemarie Katherine Cassidy. May it inspire 
her with the courage to follow her dreams, whatever they may be.  
  
	   iii	  
Acknowledgements 
 
My sincerest thanks to Gabriel Nuñez and Thirumala-Devi Kannaganti for contributing 
mice and expertise to the data outlined in Chapter 2. I’m also grateful to Jon Hagar for 
his contribution to Chapter 2, and to Darren Higgins, who provided bacterial strains 
that helped to make this work possible.  
 
Special thanks go to Luigi Franchi, who provided not only mice to this project, but 
served as my supervisor during my internship at Lycera, Corp. Luigi has been 
fantastically supportive of my development as a scientist, both academically and 
professionally.   
      
Thanks to Marie-Ève Charbonneau for major contributions to Chapter 3 and for being a 
stellar role model.  
 
Special thanks go to my committee, whose insight has made substantial contributions to 
this body of work. Thanks to Vic, for keeping this project grounded and honest. Thanks 
to Colin, for teaching me about caspase biology and apoptosis, and for providing a 
framework on which to mold my experiments. Thanks to Michele, for helping me think 
about the cell biology in a meaningful way, for providing expertise and reagents, and 
for being a professional and personal role model. And my deepest thanks to Mary, who 
has shaped my professional development in such a positive way, I am confident I will 
succeed in any future scientific endeavors.     
 
Finally, I must acknowledge the contribution of my husband, Eugene Cassidy, to the 
completion of this work. He, pursuing his own Ph. D. in History, has faithfully taken on 
well more than his share of the household chores and childcare. For the past 6 months, 
he has worked every night at the kitchen table on his own dissertation to compensate 
	   iv	  
for the time he spends during the day making sure the wheels don’t fall off our wagon. 
I am more confident and more beautiful than I have ever been at any other time in my 
life. I shine because I have the love of a person who shares my values and my passions, 
who is not above lending his t-shirt to a snotty toddler when she needs a tissue, or 
lending a hand to his wife when she needs a boost. I got so lucky snagging him, and I 
hope I never forget it.  Without him, certainly, this work would not exist.





Table of Contents 
 
Dedication           ii 
Acknowledgements         iii 
List of figures          vii 
             
Chapter 1  
More than a pore: The cellular response to cholesterol-dependent cytolysins 1 
 Abstract          1 
 1.Introduction         2 
 2. The physical properties of the CDCs      4 
  2.1 Structure and membrane binding     4 
  2.2 Oligomerization and pore formation     5 
 3. Membrane response to CDC intoxication     10 
  3.1 Endocytosis of pores       10 
  3.2 Membrane blebbing       12 
 4. Intracellular effects of CDC intoxication     15 
  4.1 Effects on the endoplasmic reticulum and Golgi    15 
  4.2 Effects on the mitochondria and nucleus    16 
  4.3 Endolysosomal network      20 
  4.4 Immune signaling       21 
 5. Conclusions         24 
 6. References          25 
 
Chapter 2 
Membrane damage during Listeria monocytogenes infection triggers a caspase-7 
dependent cytoprotective response       34 
 Abstract          34 
1. Introduction         36 
	   vi	  
2. Results          39 
 3. Discussion          56 
 4. Methods and materials        59  
 5. References          66 
  
Chapter 3            
Transient activation of caspase-7 promotes blebbing and survival in response to damage 
by pore-forming toxins          71 
 Abstract          71 
 1. Introduction         73 
 2. Results          76 
 3. Discussion          91 
 4. Materials and methods        95 
 5. References          101 
 
Chapter 4  
The contribution of cellular processes to membrane repair after LLO damage 106 
 1. Introduction         106 
 2. Results          107 
 3. Discussion          125 
 4. References          128 
 
Chapter 5 
Perspectives           131 
 References          143 
 











List of Figures 
 
Chapter 1 
1.1. CDC pore-dependent membrane repair      11 
1.2. CDC pore-dependent signaling responses      19 
 
Chapter 2 
2.1. Caspase-7 is activated in macrophages during infection  
with L. monocytogenes.         40 
2.2. Caspase-7 activation during infection with L. monocytogenes  
induces minimal apoptosis.        42 
2.3. Caspase-1 and other key mediators of innate immunity are  
individually dispensable for caspase-7 cleavage.     44 
2.4. Caspase-7 deficient BMDM are permeable to small molecules  
during infection.          47 
2.5.  Caspase-7 enhances host resistance to LLO-mediated plasma  
membrane damage.          49 
2.6. Caspase-7 is cleaved in response to membrane damage in  
the absence of infection.         52 
2.7. Damage caused by pore-forming toxins stimulates caspase-7  
cleavage.            54 
 
Chapter 3 
3.1. Transient caspase-7 activity promotes survival and membrane  
integrity in LLO-intoxicated cells.        77 
3.2. csp7-/- cells display altered blebbing compared to BL/6 cells in  
response to LLO treatment.         81 
3.3. ROCK I is cleaved in a caspase-dependent manner in response  
to LLO damage.          83 
3.4. Inhibition of ROCK and myosin impedes toxin-induced blebbing  85 
	   viii	  
3.5. Annexin A1 aggregation is reduced in csp7-/- BMDMs post intoxication. 88 
3.6. ROCK I and myosin II promote membrane fidelity during  
infection with L. monocytogenes.               90 
 
Chapter 4 
4.1. LAMP-1 staining of BMDMs in response to infection.    108 
4.2. ASM treatment of L. monocytogenes infected BMDMs.    111 
4.3. Cholesterol biosynthesis regulation during L. monocytogenes infection.   113 
4.4. Monitoring PDI as a marker of ER stress in response to PFT damage.  116 
4.5. Activation of the UPR in response to LLO damage.    119 
4.6 Autophagy is activated by exogenous LLO treatment and is reduced  
by myosin II inhibition.         123 
 
Chapter 5 
5.1. Models of caspase-7 activation        135 
5.2. Caspase-3 is activated with slower kinetics than caspase-7 in response  
to toxin treatment.          138 
5.2.  A schematic of the dichotomous roles of activated caspase-7.    142 
 
Appendix 
A1. Infection at MOI1 and MOI5 results in equivalent intracellular  
CFU by 8h pi.          148 
A2. Caspase-3 is weakly cleaved in response to L. monocytogenes infection.  149 
A3. Most L. monocytogenes infected cells do not display common markers  
of apoptosis.           150 
A4. Caspase-7 deficient cells retain LDH at similar levels as BL/6 cells  
during infection.          151 
A5. WT and iLLO strains grow to equivalent intracellular CFU by 8 h pi.   152 
A6. BMDM treated with low concentrations of exogenous LLO do not  
release LDH by 5 h pi.         153 
A7. BMDM treated with α-hemolysin release little LDH 8 h post treatment. 154 
A8. Treatment of BMDMs with LLO results in transient caspase-7  
	   ix	  
activation.           155 
A9. Caspase-7 deficient cells display slower recovery after LLO intoxication  
compared to BL/6 cells.          156 






More than a pore: The cellular response to cholesterol-dependent cytolysins 
(Published: Cassidy SKB and O’Riordan MXD (2013) Toxins 5:618-636) 
Abstract: Targeted disruption of the plasma membrane is a ubiquitous form of attack 
used in all three domains of life. Many bacteria secrete pore-forming proteins during 
infection with broad implications for pathogenesis. The cholesterol-dependent 
cytolysins (CDC) are a family of pore-forming toxins expressed predominately by 
Gram-positive bacterial pathogens. The structure and assembly of some of these 
oligomeric toxins on the host membrane have been described, but how the targeted cell 
responds to intoxication by the CDCs is not as clearly understood. Many CDCs induce 
lysis of their target cell and can activate apoptotic cascades to promote cell death. 
However, the extent to which intoxication causes cell death is both CDC- and host cell-
dependent, and at lower concentrations of toxin, survival of intoxicated host cells is 
well documented. Additionally, the effect of CDCs can be seen beyond the plasma 
membrane, and it is becoming increasingly clear that these toxins are potent regulators 
of signaling and immunity, beyond their role in intoxication. In this review, we discuss 
the cellular response to CDC intoxication with emphasis on the effects of pore 
formation on the host cell plasma membrane and subcellular organelles and whether 
subsequent cellular responses contribute to the survival of the affected cell. 
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1. Introduction 
 
     The cholesterol-dependent cytolysins (CDCs) are a family of pore-forming proteins 
expressed by several genera of pathogenic, primarily Gram-positive bacteria that cause 
very different diseases. Examples include Streptococcus pyogenes, a common cause of 
upper respiratory infections, Bacillus anthracis, which mostly causes cutaneous 
infections, and Listeria monocytogenes, which causes gastroenteritis.  The CDCs are 
secreted as soluble monomers, which upon binding to host cell membranes, can 
oligomerize to form β-barrel pores of large diameter. Although the CDCs share 
structural similarity, the role of these toxins during infection largely depends on the 
pathogen and the context of infection. For instance, data suggest the secretion of 
Streptolysin O (SLO) may protect the extracellular pathogen, S. pyogenes, from 
phagocytic killing by lysing target cells [1]. SLO translocates the S. pyogenes secreted 
effector, SPN, into target cells resulting in cytotoxicity [2]. In contrast, Listeriolysin O 
(LLO) is necessary for the intracellular pathogen, Listeria monocytogenes, to escape the 
primary vacuole and replicate within the cytosol of intact macrophages [3]. Thus, 
bacteria can exploit a common mechanism of pore formation to drive divergent cellular 
outcomes during pathogenesis.  
     CDC intoxication may result in some characteristic hallmarks of membrane damage, 
such as ion flux across the targeted cell membrane, loss of cytosolic contents, 
stimulation of repair mechanisms, and host cell lysis. However, many cellular responses 
to CDCs are poorly explained by pore-formation alone.  For instance, Tetanolysin O 
(TLO) from Clostridium tetani, stimulates the release of IL-1β, a pro-inflammatory 
cytokine, from target cells, but only at sub-lytic doses [4], which may contribute to host 
clearance of the bacteria. Others have shown that a non-cytolytic allele of pneumolysin 
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(PLY) retained the capacity to stimulate IFNγ, a cytokine capable of activating 
macrophages, in the absence of the ability to form pores [5]. Thus, the CDCs can trigger 
adaptive or inflammatory pathways within the targeted cell, independently from or in 
addition to, the damage they cause. It is also apparent that some cell types are able to 
withstand and repair lesions caused by pore-forming toxins, the molecular mechanisms 
of which are incompletely elucidated [6].  
     Many studies have used direct mutation of the CDC protein or pre-treatment with 
cholesterol to assess the signal transduction capabilities of CDC treatment in the 
absence of pore-formation. Pre-treatment with cholesterol was reported to abrogate 
pore formation, but not monomer binding of LLO [7]. Typically, loss of pore-formation 
is measured via the lysis of red blood cells [7], the release of lactate dehydrogenase 
(LDH) from target cells [2,5] and/or the visualization of pores on the target cell surface 
[7]. However, a more recent study by Hamon and Cossart demonstrated that LLO pre-
treated with cholesterol still allowed K+ flux across the plasma membrane, which 
suggests that cholesterol-treated LLO may retain some membrane damaging capacity 
[8]. Moreover, mutations in these pore-forming proteins that destroy their ability to lyse 
red blood cells may still allow some activity in other cell types, as demonstrated for the 
perfringolysin O (PFO) G461D mutant protein [9]. Thus, we note that caution should be 
taken in concluding unequivocally which host response pathways are stimulated by 
pore-formation and which are not, but include in this chapter some studies indicating 
that pore-formation is likely not the only property of the CDC proteins that can drive 
host responses.  
     Macromolecular pore-forming proteins are not unique to bacteria. Members of the 
MACPF family, including mammalian perforin and the C9 protein of the complement 
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cascade, share strikingly similar structural topology and pore-forming mechanisms 
with the CDCs [10]. The parasite, Toxoplasma gondii, secretes a pore-forming protein, 
PLP1, to promote egress from infected cells [11].  Enterolobium contortisiliquum, a tree 
native to Brazil, produces a pore-forming toxin, which functions as an insecticide and 
deterrent from ingestion [12]. The structural similarities between CDCs, perforin, and 
PLP1, for example, suggest that the target cell may sense membrane damage caused by 
these toxins in similar ways. For instance the pores produced by both CDCs and 
perforin are rapidly resealed [13,14]. As such, there are likely conserved mechanisms in 
the adaptive cellular response to intoxication by these proteins. Given that plasma 
membrane disruption is ubiquitous among all forms of life, the study of the cellular 
response to the insult of pore formation may provide insight into broadly relevant 
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2. Physical properties of the CDCs 
 
2.1 Structure and membrane binding 
     Alignment of the amino acid sequences of CDCs reveals significant identity (from 28-
99%) and similarity (> 45%) among family members [15], suggesting conservation of 
activity and structure. The four CDC proteins from different bacterial species that have 
been crystallized in their soluble monomeric form, PFO [16], intermedilysin (ILY) [17], 
anthrolysin O (ALO) [18], and suilysin (SLY) [19], all display markedly similar topology 
(CDC membrane assembly is reviewed in detail here [20]). One of the defining 
characteristics of the CDC family is a structural motif of 11 residues 
(ECTGLAWEWWR), termed the undecapeptide or tryptophan rich motif, situated at 
the membrane-binding portion of the protein. Single amino acid mutations in this motif 
alter pore formation, but recent work suggests that other elements and not the 
undecapeptide are necessary for cholesterol recognition [21]. Instead, this motif is 
proposed to control structural reorientation after cholesterol binding [22].  
     The CDC monomers are rich in β-sheets and their structures are divided into four 
domains of which D2-4 are responsible for cholesterol recognition and membrane 
insertion. The contribution of D1 is not well characterized. For all but two CDCs, 
cholesterol is necessary and sufficient for membrane binding. The exceptions are 
intermedilysin (ILY) and vaginolysin (VLY), which require an additional receptor, 
human CD59, for membrane recognition [23,24], imparting species specificity to these 
two toxins. 
 
2.2 Oligomerization and pore formation 
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    Many studies support a model where CDC monomers preferentially bind in lipid 
rafts, which are microdomains of the plasma membrane enriched for cholesterol and 
signaling molecules, because of the requirement for membrane cholesterol in pore 
formation [25-27]. Coalescence of rafts containing monomers increases the likelihood of 
monomer-monomer interaction to promote oligomerization and subsequent pore 
formation. Concurrently, raft fusion is also likely to stimulate signal transduction 
within the cell [28] (some cellular responses to CDC intoxication that occur 
independently from full pore-formation are listed in Table 1). Whether raft fusion upon 
monomer binding is host- or CDC-directed is unknown. It is possible that raft fusion 
stimulates signal transduction that occurs upon CDC membrane binding in the absence 
of pore formation [5], but this hypothesis has not been tested directly. It is interesting to 
speculate that the coalescence of lipid rafts upon CDC binding may spur signaling 
cascades that could function to trigger adaptive signaling mechanisms. For example, 
Gekara et al demonstrated that treatment of cells with LLO protein deficient in pore 
formation, but not membrane binding, retained the ability to coalesce rafts and activate 
tyrosine phosphorylation [25] . CDCs are not unique in using cholesterol or other 
components of lipid rafts for membrane binding; cholera toxin and shiga toxins use 
gangliosides enriched in lipid rafts as receptors [29,30]. The signal transduction 
stimulated by CDC binding may in part reflect a universal response to raft fusion. The 
signaling generated upon raft fusion may then license a specific survival response, such 
as membrane repair in the case of CDC binding. The specificity of the response would 
likely be ligand-receptor and context dependent, but may reflect a universal response to 
membrane lateral trafficking and perturbation.  
    When CDC monomers interact in the membrane, they undergo extensive changes in 
their secondary structure for proper membrane insertion orientation [31,32].  As  
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TABLE 1: Pore-independent cellular responses to CDC treatment. 
Response Outcome Toxin Ref 
Translocation of a bacterial effector Hydrolysis of NAD+ SLO [2] 
Lipid raft fusion Tyrosine phosphorylation LLO [20] 
IFNy secretion Inflammation PLY [5] 
iNOS production Anti-microbial PLY [5] 
Histone dephosphorylation Transcriptional modification LLO [71] 
Vaccine adjuvant Improved tumor clearance LLO [97] 
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monomers oligomerize they form a ring on the cell surface, termed the pre-pore 
complex. Pore formation occurs upon a conformational change that drives insertion of a 
β-barrel hairpin into the membrane bilayer. [33].  Much of our understanding of the 
physical characteristics of the CDC pores comes from cryo-electron microscopy and 
atomic force microscopy visualizing toxin pores on membranes [34-36], and these 
micrographs reveal both fully formed circular pores and what appear to be partial 
pores, or arcs. The argument could be made that the arcs arise as artifacts of sample 
preparation and non-native membrane conditions. However, there is evidence to 
suggest that some CDCs may form arcs under native conditions as well.  A study by 
Shaughnessey et al demonstrated the sequential release of a small dye (Lucifer Yellow, 
MW 522), termed perforation, followed by a large dye (TRDx average MW 10,000) in 
Listeria-containing phagosomes of macrophages. This perforation of the phagosomal 
membrane required the L. monocytogenes CDC, LLO [37]. These data suggest that lesions 
of different sizes occur in the phagosomal membrane during infection.  It is possible 
that CDC arcs in the membrane allow the leakage of the smaller dye, whereas full pores, 
which would have a greater diameter, allow for loss of the larger dye. Others have 
provided evidence supporting the biological existence of CDC arcs as well [34,38,39]. 
Using genetic techniques, Palmer et al demonstrated that SLO mutant proteins that 
preferentially formed arcs prevented the influx of large dextran molecules into 
erythrocytes, whereas SLO proteins that preferentially formed circular pores did not 
[38].  The role of arcs in the cellular response to toxin is not well understood. 
Nonetheless, the formation of arcs might trigger different signaling mechanisms and 
cellular responses compared to formation of the full pore, which forms a channel lined 
with protein.  The uneven disruption of the plasma membrane during arc insertion 
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would expose hydrophobic sections of membrane to the cytosol. This hydrophobicity 
could then serve as a danger signal to activate an immune response [40], a repair 
response, or both.           
     The full CDC pore is large, composed of ~35-50 monomers with a diameter of 250-
300Å, and has been used as a delivery mechanism to introduce foreign matter, such as 
antibodies, into the cytosol [41]. Despite their size, the holes formed by CDCs are 
rapidly sealed [13,42], suggesting that the host cell has efficient adaptive mechanisms to 
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3. Membrane response to CDC intoxication 
 
3.1 Endocytosis of pores      
     Once a CDC pore is inserted into the membrane, the damaged cell must heal or 
remove the lesion to maintain viability. One mechanism to achieve this is to internalize 
the damaged section of membrane via endocytosis (Fig. 1.1). Work from Norma 
Andrews and colleagues has demonstrated that when SLO inserts into the membrane, 
Ca2+ flux across the damaged membrane stimulates lysosomal exocytosis, delivering 
additional membrane to the vicinity of the lesion [43]. This process is critically 
dependent on Ca2+ [44], as is the resealing process [13]. Lysosomes contain acid 
sphingomyelinase (ASM), which hydrolyzes sphingomyelin to form ceramide. Release 
of ASM into the extracellular space after lysosomal fusion with the plasma membrane 
generates a ceramide-rich platform that can invaginate to initiate endocytosis [45,46]. 
The molecular mechanism that pinches off invaginated membrane for endocytosis is not 
fully understood.  Sphingomyelin tends to cluster with cholesterol in the plasma 
membrane [47], and thus has a high likelihood of being in close proximity to 
cholesterol-bound CDC pores. The ceramide-rich domains generated by ASM release 
can spatially reorganize receptors to activate intracellular signaling [48]. Therefore, the 
generation of ceramide-rich platforms may also act as a mechanism by which the cell 
can signal during CDC intoxication. Once internalized, SLO-containing vesicles traffic 
through the endocytic pathway to promote the degradation of the pore-forming protein 
[49]. endocytosis [45,46]. The molecular mechanism that pinches off invaginated 
membrane for endocytosis is not fully understood.  Sphingomyelin tends to cluster with 
cholesterol in the plasma membrane [47], and thus has a high likelihood of being in 
close proximity to cholesterol-bound CDC pores. The ceramide-rich domains generated  
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Figure 1.1.  CDC pore-dependent membrane repair. 
 
Figure 1.1.  A schematic of endocytosis and ectocytosis in response to CDC-induced 
plasma membrane damage. The SLO pore (blue barrel) allows for the influx of Ca2+ 
(light purple) into the cytosol. Synaptotagmin VII (sytVII, yellow) binding of Ca2+ 
stimulates the fusion of lysosomes with the plasma membrane. Fused lysosomes release 
acid sphingomyelinase (ASM, green) into the extracellular space. ASM converts 
sphingomyelin in the membrane to ceramide, which allows for invagination and 
endocytosis of toxin into the cell. Damaged caused by the SLO pore can also stimulate 
ectocytosis. Increases in cysolic Ca2+ are sensed by annexin A1 which aggregate at the 
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by ASM release can spatially reorganize receptors to activate intracellular signaling [48]. 
Therefore, the generation of ceramide-rich platforms may also act as a mechanism by 
which the cell can signal during CDC intoxication. Once internalized, SLO-containing 
vesicles traffic through the endocytic pathway to promote the degradation of the pore-
forming protein [49].  
     This model of repair is not unique to CDC-mediated membrane damage, as 
introducing a scratch wound on the cell also stimulates lysosome fusion and rapid 
repair [50]. However, this model does not apply to all types of PFT damage. For 
instance, pores formed by aerolysin, a small heptameric toxin whose pore size is 1.5-2 
nm, from Aeromonas hydrophila, are very stable in the membrane [51], and cause 
prolonged intracellular ion dysregulation compared to CDCs [42].   
 
3.2 Membrane blebbing  
     Membrane blebbing, or ectocytosis, is commonly used as a hallmark of apoptosis 
[52], but blebbing in viable cells can also promote motility and cytokinesis [53]. 
Blebbing occurs when the membrane separates from the cytoskeletal scaffold, which 
confers rigidity to the bilayer when attached. Cytoplasmic hydrostatic pressure causes 
the outward protrusion of detached membrane to form a spherical bleb (Fig. 1.1). 
Recent data suggest that membrane blebbing can also protect cells from CDC-induced 
lysis. Babyichuk et al demonstrated that treatment of cells with SLO induced membrane 
blebbing, and that this process, much like lysosomal exocytosis, was dependent on 
sufficient Ca2+ concentration in the extracellular medium [54]. Blebbing protected 
intoxicated cells by isolating the damaged section of membrane, and cells that 
underwent blebbing were more likely to survive the insult [54]. These experiments 
supported blebbing as a process by which cells could protect themselves from 
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membrane perturbation. Keyel et al used “deep-etch” electron microscopy to 
demonstrate that blebs formed in response to SLO bud from the cell surface [55]. The 
shed vesicles appeared to be enriched for SLO protein compared to lysates derived 
from whole cells. The authors concluded that membrane blebbing promotes the 
shedding of SLO-damaged membranes to promote cell survival [55]. Therefore, the 
cellular response to CDC intoxication, in this case membrane blebbing and shedding, 
can promote the survival of the affected cell. The host pathways that control 
detachment of the plasma membrane from the cortical cytoskeleton to promote 
blebbing during intoxication have yet to be determined. Additionally, the mechanisms 
by which cells that undergo blebbing and shedding replenish the plasma membrane are 
not known. Recent data revealed a role for caspase-7 in promoting plasma membrane 
integrity during CDC intoxication [56]. Since caspases promote blebbing during 
apoptosis [57,58], it is possible that CDC-induced and apoptosis-associated blebbing are 
governed by a shared molecular mechanism, although this has not yet been tested 
directly.  
     The two mechanisms of membrane repair outlined here, endocytosis and ectocytosis, 
are not inherently discordant. Although Keyel et al found no evidence of endocytosis in 
their experiments [55], it is possible that different cell types favor one mechanism over 
the other, or that the amount of damage dictates the predominant repair mechanism. It 
is also possible that these two mechanisms work in concert. Cells that bleb and shed 
damaged membrane would likely need to replace that membrane to maintain cell 
surface area and hydrostatic homeostasis, and lysosomal exocytosis could supply this 
membrane faster than making new membrane de novo. Additionally, in all cases, 
extracellular Ca2+ was critical for repair. In the endocytosis model, synaptotagmin VII, a 
calcium binding protein present in lysosomes, was required for directing the fusion of 
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these vesicles with the plasma membrane for lesion repair [50]. In the ectocytosis model, 
annexins, a family of calcium binding proteins present in the cytosol, act as a plug at the 
neck of the bleb to seal off the contents of the cytosol away from the damaged 
membrane [54]. Different concentrations of intracellular Ca2+ may trigger different 
mechanisms of membrane repair, or the relative abundance of calcium sensors in 
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4. Intracellular effects of CDC intoxication 
 
4.1 Effects on the endoplasmic reticulum and Golgi 
     Beyond the effects of CDC perturbation at the plasma membrane, there are hints that 
CDCs can also affect intracellular compartments. Pillich et al recently published a report 
suggesting that infection with L. monocytogenes can activate the unfolded protein 
response (UPR) in the endoplasmic reticulum (ER) [59]. The UPR is a stress response 
which acts to balance protein synthesis and protein folding in the ER to maintain 
cellular homeostasis [60]. UPR activation was dependent on secretion of LLO by L. 
monocytogenes [59]. Others have shown that UPR activation during intoxication with 
other pore-forming toxins is protective at the level of the organism. Loss of ire-1 or atf-6, 
two UPR sensors, in Caenorhabditis elegans results in hypersensitivity to the PFT, Cry5B 
[61]. How activation of the UPR protects cells during intoxication is not known, but 
there are several possible explanations. UPR stimulation activates autophagy [62], a 
degradative pathway responsible for the turnover of cellular contents and organelles,  
and autophagy may contribute to the degradation of PFTs, damaged membrane, or 
both. UPR activation can also stimulate lipid synthesis [63], which could enhance 
membrane repair and replenishment after toxin-induced damage. Finally, the UPR 
promotes increased vesicular traffic between the ER and the Golgi [64]. Vesicles derived 
from these compartments may contribute to membrane repair in a manner analogous to 
lysosomal exocytosis.  
     In addition to activation of the UPR, there are some clues that suggest CDCs act on 
the ER membrane directly. PFO perforates the ER [65] despite the low concentration of 
cholesterol in this bilayer [66]. LLO stimulates the rapid release of Ca2+ from the ER of 
mast cells by Ca2+ channel-dependent and -independent mechanisms [67] (Fig. 1.2), 
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indicating that LLO may act on the ER membrane as well. However, LLO pores were 
not directly detected on the ER membrane [67]. Although CDC binding to internal 
stores of membrane is an appealing model to explain aspects of CDC-mediated 
signaling, most of the data remains speculative. It is inherently difficult to tease apart 
the cellular response to CDC-damaged organelles from the signaling that occurs as a 
result of plasma membrane damage, since the former cannot be detected without 
inducing the latter. Better tools are needed to determine if CDCs act on intracellular 
compartments directly, and whether these organelles can drive CDC-specific responses 
in the absence of plasma membrane damage.   
     Although the Golgi and ER are intimately connected within the cell, less is known 
about CDC interactions with the Golgi. Treatment of cells with SLO increases Golgi-
derived trafficking to the damaged membrane [68], but this response is not likely 
specific to CDC-intoxication. Nonetheless, given the critical role for the Golgi apparatus 
in lipid metabolism and transport [69], the Golgi may play a role in modulating 
responses to CDC-derived damage. Infection with some bacterial pathogens has shed 
light on Golgi-plasma membrane interactions. Divangahi et al elegantly demonstrated 
that Mycobacterium tuberculosis infection induces plasma membrane damage and 
requires translocation of Golgi-derived vesicles to the bilayer to successfully seal lesions 
[70]. Thus, vesicular traffic from the Golgi represents an attractive source of new 
membrane and newly synthesized lipids to replace membrane lost during endo- or 
ectocytosis in response to CDC perturbation.    
          
4.2 Effects on the mitochondria and nucleus 
      CDCs exert effects on many intracellular compartments. For instance, Goldmann et 
al determined that SLO treatment of macrophages had profound effects on the 
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mitochondria of the cell, including loss of mitochondrial membrane potential, which led 
to the oncotic death of the intoxicated cell [71]. Interestingly, loss of plasma membrane 
integrity was not the sole trigger for mitochondrial dysfunction, as cell death was not 
inhibited by increased osmolarity in the culture media. Also, the pore size at the plasma 
membrane was significantly smaller than what is estimated for the SLO pore [71], 
indicating that either the pores were of mammalian origin, or that SLO arcs might be 
the predominant form of damage. Together, these results suggest that SLO potentially 
acts as a signaling molecule, in addition to its role as a PFT, with negative implications 
for the function of cellular mitochondria.  
     Another study showed that PLY intoxication affects the mitochondria of neuronal 
cells to induce apoptotic cell death, and PLY protein was detected on the mitochondrial 
membrane using immuno-EM [72].  The authors demonstrated that the ability to form 
pores at the plasma membrane was necessary to induce mitochondrial dysregulation, 
but whether PLY protein formed pores on the mitochondrial membrane was not 
assessed. It is possible that monomer binding to the mitochondrial membrane was 
sufficient to induce the response, and that pore-formation at the plasma membrane was 
needed to introduce monomers into the cytoplasmic space. Considering that the sterol 
content of the mitochondrial membrane is very low [66], it is plausible that PLY 
oligomerization in this membrane would also be low.  
     LLO alters the mitochondria as well, but differently from SLO and PLY. Stavru et al 
demonstrated that treatment of cells with non-lytic concentrations of LLO induced 
fragmentation of the mitochondrial network [73] (Fig. 1.2). Although mitochondrial 
fragmentation is sometimes used as a hallmark of programmed cell death, markers of 
apoptosis were not observed in these cells. In fact, the LLO-induced changes in 
mitochondrial morphology were transient, leading the authors to hypothesize that 
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altering mitochondrial dynamics would slow the metabolism of the cell to promote the 
early stages of L. monocytogenes infection [73]. Whether other CDCs induce a similar 
morphological change is not known. The authors implicated Ca2+ flux as important in 
eliciting this response [73]. In conclusion, it is clear that intoxication with CDCs can 
significantly alter the mitochondria of intoxicated cells, but the outcome of that 
alteration is likely cell type- and potentially CDC-specific.  
     Most of the existing knowledge of the effects of CDCs on the nucleus has come from 
the exogenous treatment of cells with LLO. LLO binding to the plasma membrane can 
stimulate specific dephosphorylation of histone H3 in the nucleus [74]. PFO and PLY 
were also able to spur histone modification, but treatment with detergents and an 
unrelated PFT was not, indicating that the response is specific to CDC membrane 
binding. These data supply direct evidence for the hypothesis that CDCs can act as 
signal transducers. Using microarrays to monitor changes in transcription, Hamon et al 
found that epigenetic changes caused by LLO binding resulted in altered expression of 
~150 genes [74]. The authors found that pre-treatment of LLO with cholesterol inhibited 
the ability of the CDC to stimulate the release of LDH from these cells, but not the 
dephosphorylation of histone H3, indicating that full pore formation was not needed to 
induce this response. In a subsequent paper Hamon et al determined that cholesterol-
treated LLO retained the ability to stimulate K+ flux across the plasma membrane, and 
that this ion flux was sufficient to stimulate histone modification [8].  
     Treatment of cells with LLO can induce the nuclear translocation of the master 
transcriptional regulator, NF-κB [75], as well as activate the MAPK cascade [76], both of 
which have the capacity to globally alter gene transcription and activate immune 
signaling (discussed below). Recent data suggest that LLO stimulates degradation of  
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Figure 1.2. CDC pore-dependent signaling responses 
 
Figure 1.2.  A schematic of the different signaling responses activated by CDC 
damage. CDC intoxicated cells activate the inflammasome, stimulating the release of IL-
1β. CDC perforated cells also secrete TNFα. Calcium is released by the ER and the UPR 
is activated in response to intoxication. CDC treatment results in loss of mitrochondrial 
membrane potential and transient fragmentation of the mitochondrial network. IL-8 is 
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human telomerase reverse transcriptase [77], although that regulation is due in part to 
Ca2+ flux as a result of membrane perturbation. Taken together, these data suggest that 
CDCs can have profound influence on transcriptional regulation of the intoxicated cell, 
which would likely affect the outcome of infection.    
 
4.3 Endolysosomal network 
            The endolysosomal network is a key cellular defense system that traps bacterial 
pathogens within a membrane bound compartment through phagocytosis or 
autophagy, and a CDC toxin, LLO from L. monocytogenes, is crucial for escape from this 
restrictive environment [78]. LLO perforates the phagosome, stimulating ion flux and 
cellular signaling [37,79]. One outcome of LLO perforation of the phagosome is to delay 
phagosome maturation [80]. While escape is the primary function of LLO-induced 
membrane damage within the vacuole, it is conceivable that pore formation permits the 
passage of other L. monocytogenes virulence factors, like PI-PLC and PC-PLC, across the 
phagosomal membrane to trigger host signaling pathways [81,82]. Phagosomal 
membrane damage induced by LLO activates autophagy, a scavenging pathway that 
targets cytoplasmic components for lysosomal degradation [83,84]. Although LLO is the 
only CDC expressed by a pathogen that is largely intracellular, some extracellular 
pathogens expressing CDC toxins, like S. pyogenes, can be found within host cells and 
their entry and survival may be influenced by CDC expression [85,86].  The structurally 
related mammalian MACPF protein, perforin, which confers cytolytic activity to T 
lymphocytes and natural killer cells, also acts from within the endolysome, delivering 
granzyme B to the cytosol of infected target cells [87].  Damage of the lysosomal 
compartment, as a consequence of pore formation, is a potent trigger of the 
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inflammasome resulting in secretion of the pro-inflammatory cytokine IL-1β [88,89]. 
Thus, LLO pore formation is critical for L. monocytogenes to escape the endosomal 
compartment, but in doing so alerts the host to its presence. 
        
4.4 Immune signaling 
      There is a large body of evidence that cells can mount an inflammatory response to 
non-lytic intoxication with CDCs, and that CDCs themselves may act as pathogen-
associated molecular patterns (PAMPs).  Intoxication with LLO can activate the MAPK 
pathway [76], a signaling cascade that promotes both innate and adaptive immune 
responses [90]. Nasopharyngeal epithelial cells secrete a neutrophil chemoattractant, IL-
8, upon intoxication with PLY, which is dependent on MAPK signaling [91]. SLO 
intoxication of neutrophils stimulates their secretion of antimicrobial peptides and 
inflammatory proteins via the activation of the MAPK cascade [92]. Treatment of 
macrophages with heat killed bacteria and either LLO or SLO activates MAPK-
dependent secretion of IL-10 [93], an anti-inflammatory cytokine, which suggests that 
the immune response to CDC intoxication is tempered by the presence of additional 
stimuli. 
     In the early 1990s, it was demonstrated that monocytes secrete TNFα and IL1β in 
response to treatment with SLO or PLY [94,95].  Approximately 10 years later, this 
cytokine release was linked to Toll-like receptor signaling, as macrophages lacking Toll-
like receptor 4 (TLR4) failed to respond to purified PLY [96]. Similar results were 
obtained treating macrophages with recombinant ALO, LLO, PFO, and SLO [97]. 
Blocking the binding of lipopolysaccharide to TLR4 did not abrogate cytokine secretion, 
suggesting that activation of TLR4 by these toxins was not due to endotoxin 
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contamination [97]. Whether CDCs act directly as a ligand of TLR4 is still not known. 
Another possibility is that binding or oligomerization of CDCs at the plasma membrane 
induces rearrangement of membrane microdomains. Coalescence of lipid microdomains 
could promote TLR4 dimerization spurring immune signaling [98]. In this way, binding 
or oligomerization of CDCs at the membrane may enhance PAMP-like signaling 
cascades.  
     In addition to activation of pattern recognition receptors at the cell surface, CDCs can 
also stimulate intracellular immune signaling. TLO treatment of LPS-primed 
macrophages activates the NLRP3 inflammasome, inducing the processing and 
secretion of IL-1β [4]. The authors concluded that full pore formation was necessary for 
cytokine secretion as pretreatment of the toxin with cholesterol was insufficient to 
stimulate the response. Whether cholesterol-treated TLO retains the ability to alter 
intracellular K+ similar to cholesterol-treated LLO [8] has not been studied. Later it was 
determined that SLO-induced inflammasome activation required TLR signaling, but 
infection with the bacterial pathogen that produces the toxin, S. pyogenes, does not [99]. 
Therefore, TLR signaling may represent a mechanism by which macrophages can 
distinguish between intoxication and direct infection with a particular pathogen in 
order to guide the proper immune response. It is important to note that NLRP3 can be 
activated by low intracellular K+ [100] and treatment of cells with CDCs can result in the 
depletion of cytosolic K+ [41]. Thus, activation of NLRP3 could represent a general 
response to membrane damage, which could be altered by additional virulence factors 
secreted by the bacterium or by a dynamic host response in the context of infection. 
However, murine splenic cells secrete IFNγ and produce iNOS in response to mutant 
PLY that appears to lack the ability to form pores [5], so cytokine secretion in response 
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to intoxication with CDCs may have damage-dependent and damage-independent 
triggers.    
     Treatment of immune cells with CDCs can modulate adaptive immune function. 
When macrophages are exposed to SLO-rich plasma membrane-derived vesicles, they 
secrete less TNF upon LPS stimulation and present fewer peptides to B cells [101].  Non-
hemolytic LLO has potent immunogenic [102] and adjuvant properties for anti-cancer 
vaccination [103]. LLO-derived epitopes were presented to CD4 and to a lesser extent 
CD8+ T cells [102], an interesting finding since CD8+ cells are responsible for anti-
tumor immunity as well as L. monocytogenes clearance [103-105]. However, when 
CD4+ T cells were directly exposed to LLO that retained pore-forming capabilities, 
these cells became anergic [106] or apoptotic [107]. Therefore, the relative levels and 
activity of CDC toxin present during infection, as well as its cellular context, regulate 
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5. Conclusions 
      An intact eukaryotic cell membrane is critical for cell survival and yet this barrier is 
routinely assaulted by CDC toxins during infection. Studies using these toxins have 
elucidated previously uncharacterized membrane repair mechanisms that also function 
to repair mechanical stresses, such a scratch wounds. Therefore, the damage responses 
discovered as a result of CDC pore formation may shed light on the mechanisms cells 
use to protect the bilayer in response to diverse insults. Studies on the morphological 
and transcriptional differences that occur during CDC treatment of cells will continue to 
guide our understanding of the host response to intoxication. Finally, signaling 
cascades activated by target cells upon CDC exposure indicate these toxins may be 
important modulators of innate and adaptive immunity, in addition to their specific 
functions in virulence. The CDC toxins have been a valuable model to study key aspects 
of host-pathogen interactions and continue to be versatile tools to investigate the 
cellular response to damage and infection, improving our understanding of host-
pathogen interactions and immunity.    
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Membrane damage during Listeria monocytogenes infection triggers a caspase-7 
dependent cytoprotective response 
(Published: Cassidy SKB et al (2012) PLoS Pathog 8, e1002628) 
 
Abstract: The cysteine protease caspase-7 has an established role in the execution of 
apoptotic cell death, but recent findings also suggest involvement of caspase-7 during 
the host response to microbial infection.  Caspase-7 can be cleaved by the inflammatory 
caspase, caspase-1, and has been implicated in processing and activation of microbial 
virulence factors.  Thus, caspase-7 function during microbial infection may be complex, 
and its role in infection and immunity has yet to be fully elucidated.  Here we 
demonstrate that caspase-7 is cleaved during cytosolic infection with the intracellular 
bacterial pathogen, Listeria monocytogenes. Cleavage of caspase-7 during L. 
monocytogenes infection did not require caspase-1 or key adaptors of the primary 
pathways of innate immune signaling in this infection, ASC, RIP2 and MyD88.  
Caspase-7 protected infected macrophages against plasma membrane damage 
attributable to the bacterial pore-forming toxin Listeriolysin O (LLO). LLO-mediated 
membrane damage could itself trigger caspase-7 cleavage, independently of infection or 
overt cell death.  We also detected caspase-7 cleavage upon treatment with other 
bacterial pore-forming toxins, but not in response to detergents.  Taken together, our 
results support a model where cleavage of caspase-7 is a consequence of toxin-mediated 
membrane damage, a common occurrence during infection.  We propose that host 
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activation of caspase-7 in response to pore formation represents an adaptive mechanism 
by which host cells can protect membrane integrity during infection.
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1. Introduction 
Pore-forming toxins are integral to the virulence of many microbial pathogens, 
including the Gram-positive bacterium, Listeria monocytogenes.  This facultative 
intracellular pathogen can cause life-threatening disease in humans, particularly in the 
very old and very young, the immunocompromised, and pregnant women [1]. In 
macrophages, L. monocytogenes gains access to its replicative niche via the action of a 
pore-forming cholesterol-dependent cytolysin, Listeriolysin O (LLO) [2].  LLO-
dependent perforation of the primary phagosomal membrane allows the pathogen to 
escape into the cytosol, where it grows to high titers in the apparent absence of overt 
cell damage until late in infection [3,4].  Virulence of L. monocytogenes therefore requires 
a delicate balance between expressing virulence factors, such as LLO, to survive host 
cell defenses while maintaining an intact host cell niche.  Infection with L. monocytogenes 
expressing an overactive allele of LLO [5,6] or with a strain that overproduces LLO [7] 
results in host cell damage and attenuation in vivo, primarily due to killing of 
extracellular L. monocytogenes by neutrophils [6]. It can therefore be inferred that the 
integrity and survival of infected host cells affects virulence of L. monocytogenes.  
  The infected macrophage plays a dichotomous role during L. monocytogenes 
infection, acting both as a reservoir for bacterial replication and as a source for 
inflammatory signals that result from recognition of microbial ligands or cellular stress.  
L. monocytogenes activates many inflammatory pathways in the cell that promote 
eventual bacterial clearance and immunity.  Infection stimulates Toll-like receptors 
TLR2 and possibly TLR5, and the Nod-like receptors (NLRs) Nod1 and Nod2, resulting 
in NF-κB-dependent pro-inflammatory gene transcription [8-12]. Cytosolic L. 
monocytogenes triggers assembly of the caspase-1 associated inflammasome, a 
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multiprotein complex whose formation can lead to an inflammatory cell death termed 
pyroptosis  [13]. Active caspase-1 processes pro-IL-1β and pro-IL-18, inflammatory 
cytokines that promote antimicrobial properties of phagocytes and stimulate adaptive 
immunity [14-16]. Several NLRs activate caspase-1 as a result of L. monocytogenes 
infection, including NLRC4, NLRP3 and AIM2, all of which require the adaptor protein 
ASC [17-20]. Studies in knockout mice have demonstrated that caspase-1 is important 
for primary clearance of L. monocytogenes, but the role of other caspases in the innate 
immune response to infection is less well defined [21].  
Caspase-7 is a member of a family of cytosolic cysteine proteases that 
promulgate diverse biological responses, including programmed cell death and 
inflammation.  Caspases can also promote cell survival, as caspase-1 positively 
regulates cholesterol biosynthesis in response to a bacterial pore-forming toxin, 
aerolysin [22]. A defining characteristic of caspases is specific cleavage of substrates at 
aspartic acid residues using a cysteine side chain as a nucleophile for peptide hydrolysis 
[23].  Caspases reside in the cytosol as zymogens that require dimerization and/or 
proteolytic cleavage before becoming catalytically active. Cleavage of caspase-7 results 
in a large and a small fragment; proteolysis between the large and small subunit is 
considered the fundamental activating event [24].  Caspase-7 was initially characterized 
as an “executioner” caspase whose activity directs the highly regulated cascade of 
events leading to cellular disassembly during apoptotic cell death ([25,26] and recently 
reviewed in [27]).  Recent studies have implicated maturation of caspase-7 as a 
consequence of infection or inflammatory stimulation.  Caspase-7 cleavage occurs 
during infection by the Gram-negative intracellular bacterial pathogens Salmonella 
enterica serovar Typhimurium and Legionella pneumophila [28,29]. In these contexts, 
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caspase-7 was cleaved by inflammasome-associated caspase-1. Caspase-7-deficient 
macrophages allowed increased L. pneumophila intracellular growth, possibly due to 
delayed macrophage cell death [29].  These studies provide evidence that caspase-7 is 
involved in host-pathogen interactions. 
     Here we show that caspase-7 cleavage is triggered by membrane damage during 
L. monocytogenes infection, and is dissociated from canonical markers of apoptosis.  
Caspase-7 cleavage occurred in the absence of caspase-1, distinct from the activation 
cascade observed during infection by S. Typhimurium and L. pneumophila [28,29]. 
Infected macrophages lacking caspase-7 exhibited increased plasma membrane 
permeability, which required ongoing production of LLO.  Treatment of host cells with 
sublytic concentrations of recombinant LLO, as well as a pore-forming toxin from 
Staphylococus aureus, α-hemolysin, triggered caspase-7 activation in the absence of 
infection.  Together, these data lead us to propose that caspase-7 activation is  
protective host response to plasma membrane damage that limits subsequent 
cytotoxicity during bacterial infection.    
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2. Results 
Caspase-7 cleavage is induced by L. monocytogenes infection without concomitant 
induction of apoptosis. 
We first investigated whether hallmarks of proteolysis associated with caspase-7 
activity could be detected in L. monocytogenes infected cells.  To this end, we infected 
bone marrow derived macrophages (BMDM) from C57BL/6 (BL/6) mice with either a 
WT strain of L. monocytogenes, or with a strain lacking the hly gene, which encodes the 
pore-forming toxin Listeriolysin O (LLO- strain). The LLO- strain cannot escape the 
primary phagosome and does not replicate within macrophages.   At 8 h pi, we assessed 
DEVDase activity, an indicator of caspase-3/7 proteolytic activity, by measuring 
cleavage of a luminescent DEVD containing substrate in cell lysates (Fig. 2.1A).  Both 
caspase-3 and -7 are able to cleave exogenous DEVD substrate, but recent studies 
suggest that proteases have overlapping but distinct physiological substrates within the 
host cell [30].  We detected an increase in DEVD-specific enzymatic activity in response 
to infection with WT, but not the LLO- mutant, indicating that bacterial uptake per se 
was insufficient to stimulate DEVDase activity.  The difference in DEVDase activity 
between cells infected at MOI1 vs MOI5 was not attributable to differences in the 
number of infected cells (Fig. 2.1B) nor the number of bacteria, as we isolated nearly 
equivalent CFU from cultures infected under these conditions at 8 h pi (Fig. A1).  At 
MOI1 and MOI5, 80-90% of cells were infected, although at MOI5, macrophages 
contained higher numbers of bacteria at early time points.   To specifically determine if 
caspase-7 was activated during L. monocytogenes infection, we investigated whether L. 
monocytogenes infection induced caspase-7 cleavage in BMDM by lysing infected cells at  
8 h pi and analyzing caspase-7 by immunoblot using an antibody that recognizes both 
the full length protein and the larger cleavage product (Fig. 2.1C).  We observed cleaved 
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Figure 2.1.  
Figure 2.1. Caspase-7 is activated in macrophages during infection with L. 
monocytogenes. (A) BL/6 BMDM were infected at the indicated MOI with either WT L. 
monocytogenes or with a mutant strain lacking the hly gene encoding listeriolysin O 
(LLO-). For this and all future experiments, BMDM infected with the LLO- strain were 
infected at MOI5. Cells were assessed for enzymatic activity 8 h pi. (B) The percentage 
of cells infected with L. monocytogenes at 8 h pi at the given MOI was assessed using 
fluorescence microscopy and Metamorph software. (C) BL/6 and csp7-/- BMDMs were 
infected and cell lysates were probed for the cleavage of caspase-7 by immunoblot using 
an antibody that recognizes both full length and cleaved caspase-7 protein.  The paired 
panels for full length and cleaved caspase-7 shown in this and all other immunoblots 
are from the same blot, but were cut to allow for longer exposure of the cleaved 
fragment.  (D) BL/6 macrophages were infected with L. monocytogenes, lysates were 
harvested at the indicated times post infection and probed for caspase-7 protein. (A-D) 
are representative of no less than three independent experiments. * P < 0.05, ** P < 0.01 
and *** P < 0.001, generated using unpaired t-tests. ns = not significant. 
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uninfected (mock) BMDM or BMDM infected with the LLO- strain (MOI 5), suggesting 
bacterial occupancy of the phagosome was insufficient to stimulate cleavage of this 
protease.  Full-length caspase-7 protein was detected in BL/6 BMDM in all samples and 
was used as a protein loading control since the overall abundance of the cleaved 
caspase-7 product was low compared to full length.  We also assessed caspase-3 
cleavage during L. monocytogenes infection by immunoblot (Fig A2). Although we 
detected cleavage of caspase-3 in response to infection, the cleavage of caspase-7 in 
response to infection was more robust, and we therefore decided to further investigate 
caspase-7. To determine the kinetics of caspase-7 activation during infection, we 
assayed cell lysates for cleavage at 2, 4, 6 and 8 h pi (Fig. 2.1D). Cleavage of caspase-7 
was detected between 4 and 8 h pi, by which time the majority of L. monocytogenes are 
replicating in the cytosol. Taken together, these data indicate that caspase-7 is activated 
during L. monocytogenes infection, and requires LLO.  
 Caspase-7 was originally identified as an executioner caspase whose activity was 
associated with activation of the apoptotic cascade [31]. To determine whether caspase-
7 cleavage was also associated with molecular markers of programmed cell death 
during L. monocytogenes infection, we first quantified the number of infected cells at 8 h 
pi by staining samples with anti-Listeria antibody, followed by immunofluorescence 
microscopy (Fig. 2.1B). We then prepared infected cell cultures for TUNEL staining to 
visualize DNA fragmentation. BMDM were exposed to L. monocytogenes at MOI1 or 
MOI5, and at 8 h pi cells were fixed and analyzed for DNA fragmentation by 
immunofluorescence microscopy. In agreement with previous findings [3], we found no 
significant increase in DNA fragmentation in cells infected at MOI1 compared to 
uninfected control cells (Fig. 2.2A).  At MOI5, there was a statistically significant 
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Figure 2.2 
 
Figure 2.2. Caspase-7 activation during infection with L. monocytogenes induces 
minimal apoptosis. (A) BL/6 macrophages were infected and assessed for TUNEL 
staining as a marker of apoptosis 8 h pi. DNAse treatment was used as a positive 
control for DNA fragmentation. P values were generated using unpaired t-tests of no 
less than 300 cells per condition. (B) Lactate dehydrogenase (LDH) release into cell 
culture supernatants was measured 8 h pi as a marker of cell integrity. The amount of 
LDH released as the result of detergent induced lysis was set to 100% and the signal 
from untreated cells was set as baseline. (A and B) are representative of no less than 
three independent experiments. * P < 0.05, ** P < 0.01 and *** P < 0.001, generated using 




























































	   43	  
increase in the number of TUNEL positive cells compared to uninfected cells.  However, 
comparing the overall number of TUNEL positive cells even in the MOI5 infection (~10-
15%) to the number of cells infected (80-90%), we conclude that the majority of cells 
infected with L. monocytogenes do not display this characteristic hallmark of apoptosis 
by 8 h pi. We obtained similar results using Annexin V to measure phosphatidylserine 
exposure, an early event in apoptotic cell death (Fig. A3).  We also measured lactate 
dehydrogenase (LDH) release at 8 h pi as an indicator of overall cell viability (Fig. 2.2B). 
L. monocytogenes infection induced a modest but notable increase in LDH release at 8 h 
pi compared to uninfected cells. This range is consistent with previously published 
reports [3], and indicates that at low MOI the majority of cells infected with L. 
monocytogenes retain LDH.  We conclude from these results that L. monocytogenes 
infection stimulates caspase-7 cleavage, but is not predominantly associated with 
molecular markers of apoptotic cell death. 
 
Key regulators of innate immune signaling are dispensable for caspase-7 activation 
during L. monocytogenes infection 
 L. monocytogenes infection triggers activation of caspase-1, and during some 
bacterial infections, caspase-7 can be a substrate of caspase-1 [28,29].  We therefore 
tested whether the activation of caspase-7 during L. monocytogenes infection was 
dependent on the presence of caspase-1 by infecting csp1-/- BMDM and measuring 
DEVDase activity. We detected increased DEVDase activity upon infection of caspase-1 
deficient BMDM (Fig. 2.3A).  Analysis of caspase-7 protein by immunoblot of infected 
cell lysates definitively revealed cleavage of caspase-7 in csp1-/- BMDM upon infection, 
and this cleavage was dependent on LLO (Fig. 2.3B). ASC is a key adaptor protein 
necessary for caspase-1 activation during inflammasome formation [32]. To determine if  
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Figure 2.3. 
 
Figure 2.3. Caspase-1 and other key mediators of innate immunity are individually 
dispensable for caspase-7 cleavage. (A) Caspase-1 deficient and BL/6 BMDM were 
infected as indicated and lysed at 8 h pi.  DEVDase activity in the lysates was measured 
by Caspase-Glo 3/7 assay.  Signal from assay buffer alone was subtracted from all the 
sample values.  (B) BMDM were infected as in (A) and cells were lysed at 8 h pi.  
Lysates were subjected to SDS-PAGE and immunoblotting with an anti-caspase-7 
antibody that recognizes both full length and cleaved caspase-7 protein. (C) BL/6, 
MyD88- deficient and RIP2-deficient BMDM were infected as indicated and lysed at 8 h 
pi.  DEVDase activity in the lysates was measured by Caspase-Glo 3/7 assay.  Signal 
from assay buffer alone was subtracted from all the sample values.  (D) BMDM were 
infected as in (A) and cells were lysed at 8 h pi.  Lysates were subjected to SDS-PAGE 
and immunoblotting with the anti-caspase-7 antibody.  Statistical significance was 
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ASC was necessary for caspase-7 cleavage, we assayed caspase-7 cleavage in infected 
Asc-/- BMDM and found that caspase-7 activation also did not require ASC during L. 
monocytogenes infection (data not shown). These data demonstrate that the mechanism 
of caspase-7 cleavage during L. monocytogenes infection does not require caspase-1, and 
thus appears to be distinct from mechanisms reported for other intracellular bacterial 
pathogens.  
 Extracellular (TLR2 and TLR5) and intracellular (Nod1 and Nod2) pattern 
recognition receptors are able to sense L. monocytogenes and direct transcription of 
cytokines and chemokines to promote inflammation and clearance [8-12].  To determine 
whether these bacterial recognition pathways contributed to caspase-7 activation upon 
infection, we evaluated L. monocytogenes-induced DEVDase activity and caspase-7 
cleavage in BMDM from myd88-/- and rip2k-/- mice. MyD88 is a critical adaptor that 
mediates signaling for 9 of the 10 TLRs with known ligands. RIP2 is a protein kinase 
that mediates inflammatory signaling through Nod1 and Nod2. We observed infection-
induced DEVDase activity and caspase-7 cleavage in myd88-/- and rip2k-/- BMDM at 
levels comparable to WT BMDM (Fig. 2.3C and 2.3D). We also detected caspase-7 
cleavage in nod1-/- and nod2-/- macrophages comparable to WT (data not shown). From 
these results, we conclude that the innate immune signaling pathways regulated by 
MyD88-dependent TLRs, Nod1, Nod2, ASC, and caspase-1 are individually dispensable 
for caspase-7 activation during L. monocytogenes infection.        
 
Caspase-7 deficient BMDM are permeable to small molecules during infection 
     Since caspase-7 was cleaved during infection with L. monocytogenes, we hypothesized 
that the activity of this enzyme could impact intracellular infection.  We therefore 
measured L. monocytogenes replication in BL/6 and csp7-/- BMDM in an antibiotic 
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protection assay where 50µg/ml of the cell impermeant antibiotic gentamicin was 
added 30 min pi to eliminate extracellular bacteria (Fig. 2.4A). We observed significant 
decline in the number of intracellular bacteria over time within the csp7-/- BMDM 
compared to BL/6 cells.   We considered the possibility that csp7-/- cells were becoming 
permeable to gentamicin, allowing antibiotic influx into the intracellular space, killing 
intracellular bacteria. To test this idea, we performed a gentamicin washout, removing 
gentamicin from the medium 2 h pi, after which antibiotic-free medium was added and 
replaced every hour to limit extracellular bacterial growth (Fig. 2.4B). When gentamicin 
was removed from the extracellular space, there was no significant difference in 
bacterial replication between BL/6 and csp7-/- macrophages. These data suggest 
increased plasma membrane permeability of L. monocytogenes-infected macrophages in 
the absence of caspase-7.  
   To more directly assess membrane integrity of L. monocytogenes infected BMDM, 
we evaluated their permeability to small fluorescent molecules during infection. At 8 h 
pi we exposed live infected cells to rhodamine-phalloidin (rho-phall), a small (1200 Da) 
cell impermeant compound that binds F-actin in the host cell. After a 15-minute 
exposure, the cells were fixed and counter-stained with DAPI.  Permeability to rho-
phall was compared between csp7-/- and BL/6 BMDM using epifluorescence microscopy 
(Fig. 2.4CD). Untreated BMDM excluded rho-phall, while cells treated with Triton X-
100 were fully permeable to rho-phall (Fig. 2.4C insets).  Although rho-phall 
permeability was similar between genotypes in the absence of infection, during 
infection the overall number of cells stained with phalloidin was significantly greater in 
the csp7-/- macrophages compared to wildtype BMDM.  Notably, despite permeability to  
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Figure 2.4 
 Figure 2.4.  Caspase-7 deficient BMDM are permeable to small molecules during 
infection. (A) BMDM were infected with L. monocytogenes and gentamicin (480 Da) was 
added 30 min pi to abrogate extracellular bacterial growth.  (B) Cells were infected as in 
(A), but beginning at 2 h pi, cells were washed with PBS and replenished with antibiotic 
free medium once an hour to limit extracellular bacterial growth.  (C) BL/6 and csp7-/- 
cells infected for 8 hwith L. monocytogenes were incubated with rhodamine-phalloidin 
(rho-phall) (~1200 Da) for 15 min prior to fixation and DAPI counterstain. The insets 
show rho-phall staining of mock treated and Triton X-100 treated BL/6 macrophages. 
Samples were visualized by epifluorescence microscopy.  (D) Cells were treated as in 
(C) and rho-phall influx was quantified by fluorescence microscopy (300 cells were 
counted per condition per experiment).  Error bars represent standard deviation from 
the mean.   All conditions were measured in triplicate, and all experiments were 
repeated ≥ 3 times.  Statistics were calculated using the Student’s unpaired t-test; 
*p<0.05, **p<0.01 and ***p<0.001. 
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small molecules, infected csp7-/- cells displayed no significant increase in LDH release at 
8 h pi compared to control cells (Fig. A4).  These findings suggest that membrane 
damage occurring during L. monocytogenes infection may be transient, and is insufficient 
to allow efflux of the large LDH tetramer (≈137,000 Da) [33]. Taken together, these data 
indicate that caspase-7 promotes plasma membrane integrity during infection with L. 
monocytogenes.   
 
Plasma membrane instability during L. monocytogenes infection requires LLO  
 Plasma membrane damage during L. monocytogenes infection could be the result 
of toxin-mediated pore formation. To determine whether bacterial protein synthesis 
was needed to induce host membrane instability, we treated infected cells with a 
bacteriostatic concentration of erythyromycin (erm), a macrolide antibiotic that targets 
the bacterial 50S ribosomal subunit.  Erythromycin was added to infected cells at 2 h pi, 
and at 8 h pi we found a significant reduction in the number of caspase-7-deficient 
phalloidin positive cells upon inhibition of bacterial protein synthesis (Fig. 2.5A). We  
then tested the requirement for LLO in driving the plasma membrane damage we 
observed in infected caspase-7 deficient macrophages.  LLO is an oligomeric cytolysin 
that forms pores in cholesterol-containing membranes [34]. The oligomerization of LLO 
occurs optimally at acidic pH [5,35] but still maintains some pore-forming activity at 
neutral pH [36-38]. LLO is actively produced by cytosolic L. monocytogenes [39].  We 
hypothesized that LLO production by cytosolic bacteria could result in continual but 
transient membrane damage during infection, which was exacerbated in csp7-/- cells. To 
test this hypothesis, we used a strain of L. monocytogenes with LLO expression 
controlled by an IPTG inducible promotor (iLLO) [40]. We transiently induced 
production of LLO during infection by the iLLO-expressing strain to permit escape  
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Figure 2.5 
 
Figure 2.5.  Caspase-7 enhances host resistance to LLO-mediated plasma membrane 
damage. (A) Caspase-7-deficient and BL/6 BMDM were infected with L. monocytogenes.  
At 4 h pi, 10mg/ml erythromycin (erm) was added to the medium to inhibit bacterial 
protein synthesis, and was maintained for the duration of the experiment.  At 8 h pi, the 
cells were incubated with rho-phall and visualized by fluorescence microscopy as in 
Fig. 3CD to measure permeability.  (B) BMDM were infected with WT L. monocytogenes 
or a bacterial strain expressing an inducible allele of LLO (iLLO).  BMDM infected with 
the iLLO strain were incubated with 1mM IPTG as indicated.  Intracellular colony 
forming units were measured at 8 h pi.  (C) BL/6 BMDM were infected as in (B), and 
rhod-phall influx was quantified at 8 h pi by epifluorescence microscopy.  (D) Caspase-
7-deficient BMDM were infected as in (B), and rho-phall permeability was quantified at 
8 h pi by epifluorescence microscopy.   Statistics were calculated using the Student’s 
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from the phagosome, and then removed IPTG from the cell culture medium.  
Determination of endpoint CFU at 8 h pi in BL/6 macrophages infected with the WT 
and iLLO strains revealed no significant differences in the number of intracellular 
bacteria between strains (Fig. 2.5B). However, IPTG removal at 2 h pi resulted in 
significantly less phalloidin permeable BL/6 BMDM infected with the iLLO strain 
compared to cells infected with WT bacteria at 8 h pi (Fig. 2.5C). The reduction of 
permeability in csp7-/- macrophages infected with the iLLO-expressing strain compared 
to the WT strain was even more pronounced, supporting a protective role for this 
protease against infection associated membrane damage (Fig. 2.5D).  Increasing 
induction time from 2 to 4 hours increased the number of phalloidin positive cells in 
both genotypes. Therefore, we conclude that LLO is required to drive the membrane 
permeability defect in macrophages lacking caspase-7. 
 
Pore formation by exogenous toxin is a trigger for caspase-7 cleavage   
Bacterial production of LLO was required for permeability of caspase-7 deficient 
macrophages during infection (Fig. 2.5), leading us to question whether LLO was also 
the trigger that stimulated cleavage of caspase-7.  To test this possibility, we infected 
BMDM with L monocytogenes, and then added 10 μg/ml erm at 2 h pi to inhibit bacterial 
protein synthesis and assayed for caspase-7 cleavage by immunoblot.  We were unable 
to detect cleavage of caspase-7 when erm was added to infected cell cultures, 
demonstrating that bacterial protein synthesis was necessary to stimulate this response 
(Fig. 2.6A).  We also infected BMDM with the IPTG-inducible LLO expressing strain, 
incubating with IPTG for 2h pi to promote vacuolar escape, followed by removal of 
IPTG from the medium to limit LLO production. Although the iLLO and WT strains 
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grew to equivalent intracellular CFU under these conditions (Fig. A5), we only 
observed caspase-7 cleavage in cells infected with the WT strain, not the iLLO strain 
(Fig. 2.6A).  LLO is one of a large family of cholesterol dependent cytolysins (CDC) 
produced by Gram-positive bacterial pathogens.  To determine whether activation of 
caspase-7 during bacterial infection was specific to LLO, or whether other CDC toxins 
behaved similarly, we infected wildtype and caspase-7-/- BMDM with L. monocytogenes 
expressing the related CDC toxin perfringolysin O (PFO) instead of LLO [41].   L. 
monocytogenes expressing PFO also stimulated caspase-7 activation (Fig. 2.6B). Thus, we 
find that cytosolic bacterial replication per se is insufficient to stimulate caspase-7 
cleavage, and that ongoing production of toxin is necessary for activation of the 
protease during L. monocytogenes infection.  
We next asked if exogenous LLO could activate caspase-7 independent of 
infection. To this end, we first determined the sublytic concentration range of purified 
recombinant LLO (rLLO), using LDH release as a marker for loss of viability at 1 h post 
treatment (Fig. 2.6C).  We then probed cell lysates incubated for 1 h with rLLO for 
caspase-7 cleavage by immunoblot.  Concentrations of exogenous rLLO, i.e., 0.25μg/ml, 
that only induced a low level of LDH release (~5%) from BMDM up to 5 h pi (Fig. 2.6C 
and A6) were sufficient to stimulate caspase-7 cleavage (Fig. 2.6D).  As we increased the 
concentration of exogenous LLO, we saw a concomitant increase in LDH release that 
correlated with more robust caspase-7 cleavage (Fig. 2.6CD). These data demonstrate 
that sublytic concentrations of LLO can activate caspase-7 in the absence of infection.  
To address whether LLO in its native conformation was necessary to stimulate caspase-
7 cleavage, we heat-treated the protein for 10 minutes at 65°C (LLO*), and compared 
caspase-7 cleavage against cells intoxicated with the same concentration of native  
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Figure 2.6 
 
Figure 2.6. Caspase-7 is cleaved in response to membrane damage in the absence of 
infection. (A) BL/6 BMDM were infected with the indicated strains and lysed at 8 h pi.  
Lysates from uninfected (mock), mock infected cells treated with erythromycin (erm), 
WT infected, WT infected + erm 2h pi, iLLO infected + IPTG for 2h pi, and LLO- 
infected were subjected to SDS-PAGE and immunoblot analysis with an anti-caspase-7 
antibody that recognizes both the full length and cleaved protein. (B) BL/6 BMDMs 
were infected with a strain of L. monocytogenes expressing PFO in place of LLO and cell 
lysates were harvested at the given times post infection. Lysates were probed for 
caspase-7 protein using the anti-caspase-7 antibody. (C) BL/6 macrophages were 
incubated with the indicated concentrations of recombinant LLO protein for 1 h after 
which the media was assayed for lactate dehydrogenase activity. The amount of LDH 
release from detergent lysed cells was set to 100% and the LDH released from untreated 
cells was set to 0%. (D) BMDMs treated as in (C) were lysed at 1 h post treatment and 
assayed for caspase-7 cleavage by SDS-PAGE and immunoblot.  The LLO* sample was 
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protein. When LLO was heat-inactivated, we observed significantly less caspase-7 
cleavage compared to cells treated with active toxin (Fig. 2.6D). These data show that 
native LLO is necessary for induction of caspase-7 cleavage.  One interpretation of these 
data could be that a native epitope of LLO stimulates caspase-7 cleavage through 
binding of a host receptor at the plasma membrane.  However, since we observed LLO-
dependent caspase-7 cleavage whether LLO was extracellular or in the cytosol, we 
propose instead that LLO triggers caspase-7 cleavage through pore formation.  
 
Pore-forming toxins, but not detergents, stimulate caspase-7 cleavage 
     To address whether caspase-7 cleavage occurs as a general response to membrane 
damage, we assessed the ability of exogenous detergent treatment to activate the 
protease. Digitonin is a non-ionic glycoside detergent that can reversibly permeabilize 
the plasma membrane by forming complexes with cholesterol [42]. To determine if 
caspase-7 could be activated in response to detergent permeabilization, we treated 
BMDM with lytic and sublytic concentrations of digitonin and probed for caspase-7 
cleavage 1 h post treatment by immunoblot. Although digitonin treatment induced 
plasma membrane damage, as assessed by measuring LDH release (Fig 2.7A), detergent 
treatment did not stimulate caspase-7 cleavage at any concentration tested (Fig. 2.7B). 
We obtained similar results using a sublytic to lytic range of the detergents Nonidet P-
40, Triton-X100, Tween-20 and saponin (data not shown). These data indicate that 
plasma membrane damage alone is insufficient to stimulate caspase-7 activation.  
      We then asked if caspase-7 cleavage could be stimulated by other pore-forming 
toxins (PFT).  Staphylococcus aureus a-hemolysin is a well studied PFT distinct from the 
CDC family of toxins.  Treatment of BMDM with α-hemolysin resulted in little to no  
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Figure 2.7 
 
Figure 2.7. Damage caused by pore-forming toxins stimulates caspase-7 cleavage. 
(A) BMDMs were treated with digitonin for 1 h after which the cell media was tested 
for lactate dehydrogenase activity. (B) BMDM treated as in (A) were lysed 1 h post 
treatment and assayed for caspase-7 cleavage by SDS-PAGE and immunoblot using an 
antibody that recognizes both the full length and cleaved protein. Treatment of BMDM 
with 0.75 μg/ml recombinant LLO was included as a control for caspase-7 cleavage. (C) 
BL/6 BMDM were treated with varying concentrations of α-hemolysin (Sigma-Aldrich) 
and cell media was tested for lactate dehydrogenase activity 1 h post treatment. The 
amount of LDH release from detergent lysed cells was set to 100% and the LDH 
released from untreated cells was set to 0%. (D) BMDM were treated with 100 μg/ml α-
hemolysin and were lysed at the given times post treatment. Lysates were probed for 
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LDH release up to 8 h post treatment (Fig 2.7C and A7), consistent with previous 
reports that nucleated cells can repair damage caused by this toxin [43-45]. To test the 
pore-forming ability of the toxin we confirmed it was lytic on red blood cells (data not 
shown). α-hemolysin did trigger caspase-7 activation as early as 5 min post treatment 
(Fig 2.7D). Some cells types activate the apoptotic cascade in response to treatment with 
low doses, but not high doses, of α-hemolysin [46,47]. However we observed no 
morphological hallmarks of apoptosis up to 8 h post toxin treatment (data not shown). 
These results suggest that caspase-7 activation is generally responsive to membrane 
damage by bacterial pore-forming toxins.            
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3. Discussion 
 Here we report that caspase-7 protects plasma membrane integrity during 
infection with L. monocytogenes.  We found that the transient membrane damage 
observed during infection was dependent on the pore-forming toxin, LLO. We also 
showed that caspase-7 cleavage by L. monocytogenes infection did not individually 
require caspase-1, ASC, MyD88-dependent TLR, or Nod1 and Nod2 signaling.  Instead, 
we found that sublytic membrane damage by recombinant LLO and α-hemolysin, even 
in the absence of infection, could stimulate caspase-7 activation. L. monocytogenes 
expressing PFO also stimulated caspase-7 activity. However, treatment of BMDM with 
sublytic concentrations of detergent did not trigger caspase-7 cleavage. These data 
suggest that general membrane damage or changes in ion gradients across the 
membrane are insufficient to stimulate caspase-7 and the subsequent cytoprotective 
response. Although these observations do not rule out a role for pattern recognition of 
specific microbial ligands in activation of caspase-7, our results suggest the possibility 
that caspase-7 participates in sensing and/or repair of PFT-induced membrane damage 
in the infected cell by a caspase-1 independent mechanism.  Given the abundance and 
importance of PFTs for many pathogens, we propose a model whereby caspase-7 is 
induced by plasma membrane damage that occurs during microbial infection and 
initiates mechanisms of phagocyte membrane repair to protect the infected cell.  
 Caspases are well studied for their pivotal roles in apoptotic and inflammatory cell 
death cascades. However, there is a growing body of evidence that links caspase 
activation to additional cellular functions, independent from those leading to cell death. 
For instance, in vitro and in vivo studies indicate that caspase-7 cleaves and is regulated 
by sterol regulatory element binding proteins (SREBPs), transcription factors bound to 
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endoplasmic reticulum (ER) and nuclear membranes [48,49]. When cells are depleted of 
cholesterol, proteolytic cleavage of SREBPs results in their nuclear translocation and 
subsequent transcription of genes responsible for cholesterol biosynthesis and 
lipoprotein uptake [50]. Gurcel et al demonstrated that activation of SREBPs in response 
to the pore-forming toxin, aerolysin, promoted intoxicated cell survival in a caspase-1 
dependent manner [22].  However, in our studies, activation of caspase-7 did not 
require caspase-1.  Moreover, we observed no analogous upregulation of cholesterol 
biosynthesis genes (data not shown).  Caspases can also regulate virulence 
determinants during intracellular infection. Caspase-3, a canonical “executioner” 
caspase highly related to caspase-7, was recently shown to cleave the Salmonella type III 
secreted effector protein SipA [51].  Processing of SipA was necessary for the generation 
of inflammation in mouse infection models, and inflammatory signaling is critical for 
Salmonella pathogenesis [52], suggesting co-evolution between host and pathogen to 
promote bacterial virulence in this context.   Caspase-mediated cleavage of pathogen-
derived proteins can also function to attenuate virulence. For instance, caspase-7 
cleavage of ORF57, an early protein critical for viral replication during KSHV infection, 
inhibits the expression of viral lytic proteins, thereby limiting viral spread [53].  Taken 
together, these studies demonstrate that caspases play a complex role during microbial 
infection, and individual caspases may act in a manner that benefits the host and/or the 
pathogen. 
The mechanisms by which the host cell defends itself from LLO-mediated 
toxicity or damage by other microbial virulence factors are not fully understood, 
although the concept of plasma membrane or phagosomal membrane damage as a 
signature of pathogenesis has been recognized [4,54]. Infection-associated signals, such 
as flagellin or membrane damage, may be sensed such that weak signals trigger a 
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protective response, whereas strong signals result in initiation of programmed cell 
death through pyroptosis or apoptosis.  Sublytic levels of membrane damage by pore 
formation may send a “weak” signal, inducing adaptive mechanisms of membrane 
repair.  Indeed, several groups have demonstrated that mammalian cells can tolerate 
sublytic concentrations of the related cytolysin, Streptolysin O, which causes transient 
membrane perforations that allows delivery of large macromolecules into live cells [55-
57]. Repair of such membrane lesions can occur by the exocytosis of lysosomes to the 
site of injury, followed by endocytosis of the damaged section of membrane [55,58].  
Previous studies indicate that LLO is actively produced by cytosolic L. monocytogenes 
[39] and therefore LLO could cause ongoing transient membrane damage throughout 
the infection that is kept in check by membrane repair.  Investigating the pore forming 
toxin, BT toxin, from the invertebrate pathogen Bacillus thuringiensis, Bischof et al 
reported that intoxication of C. elegans and mammalian cells stimulated the unfolded 
protein response (UPR), a stress-related mechanism aimed at maintaining protein 
homeostasis in the ER, and that activation of this stress response was critical for 
nematode defense against the toxin [59]. Recent studies suggest the UPR is activated in 
response infection with L. monocytogenes [60]. Whether caspase-7 acts analogously or 
together with the UPR as a defense mechanism to protect host membrane integrity 
remains to be elucidated. Given that membrane-damaging virulence factors are 
virtually ubiquitous among bacterial pathogens, we propose that caspase-7 may 
represent a broad mechanism by which the host cell can sense this common insult and 
protect itself from ongoing damage.  
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4. Materials and Methods 
Ethics Statement 
Humane animal care at the University of Michigan is provided by the Unit for Lab 
Animal Medicine, which is accredited by the American Association for Accreditation of 
Laboratory Animal Care and the Department of Health and Human Services.  This 
study was carried out in strict accordance with the recommendations in the Guide for 
the Care and Use of Laboratory Animals of the National Institutes of Health. The 
protocol was approved by the Committee on the Care and Use of Animals (UCUCA) of 
the University of Michigan (#A3114-01).  
 
Bacterial Strains and Reagents 
BMDM were infected with Listeria monocytogenes strain 10403S (WT), DP-L2161  
(LLO-) [41] which has an in-frame deletion of the hly gene, DH-616 (iLLO) [40] whose 
allele of the hly gene is controlled by an IPTG inducible promotor, and DPL-1875 [41], a 
hly deletion strain expressing pfo (perfringolysin O) using the hly promoter. The anti-
caspase-7 antibody, which recognizes full length and cleaved caspase-7 (cat #9492) was 
purchased from Cell Signaling Technology. Rhodamine-phalloidin (cat #R415) was 
purchased from Molecular Probes. Digitonin and α-hemolysin were purchased from 
Sigma-Aldrich.  
 
Cell Culture and Infection 
Bone marrow derived macrophages (BMDM) were isolated from WT C57BL/6 mice, 
except where targeted mutations were indicated.  All genetically deficient strains of 
mice used were constructed in this background. BL/6 and csp7-/- mice were bred by the 
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G. Nuñez lab, the T-D Kanneganti lab, and Jackson Laboratories (Bar Harbor, Maine). 
Mice from the G. Nuñez lab were sacrificed and marrow was isolated immediately after 
necropsy. Mice from the T-D Kanneganti lab and Jackson Laboratories were sacrificed, 
their rear legs isolated and shipped overnight in media on ice to the O'Riordan lab, and 
marrow was isolated the next morning. Briefly, isolated BMDM were differentiated in 
DMEM with 20% heat-inactivated FBS (Hyclone Laboratories), 1% L-glutamine, 1% 
sodium pyruvate and 30% L929 fibroblast conditioned medium.  Cells were cultured in 
non-TC treated plates, fed with fresh media on day 3 and harvested on day 6 for 
infection on day 7. Cultures were maintained in a humidified incubator at 37°C with 5% 
CO2. Overnight cultures of L. monocytogenes in BHI broth were incubated statically at 
30°C. Prior to infection, bacteria were pelleted and resuspended in PBS.  
     For experiments with the iLLO strain, cultures were grown overnight statically at 
30°C in BHI + 1mM IPTG. Before infection, cultures were back diluted 1:10 in fresh BHI 
with 1mM IPTG and grown with shaking at 37°C until an OD600 of 1.2 was achieved, at 
which point bacteria were pelleted and resuspended in PBS to be used for inoculation of 
cell cultures. All other strains was treated equivalently, but without IPTG. When iLLO 
was used to infect cells, 10mM IPTG was added to the cell culture media for the 
indicated times post infection. Cells were infected at MOI1 or MOI5 for most strains and 
MOI10 for iLLO to compensate for decreased phagosomal escape of the iLLO strain. 
When infected in this manner, the WT and iLLO strains grew with similar kinetics and 
cells supported equivalent intracellular growth at 4 (data not shown) and 8 h pi (Fig 
2.5B).     
  
Caspase-7 cleavage 
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Two million BMDM were plated in 60mm dishes 18 hprior to infection. Cells were 
infected at MOI5 for 30 minutes, after which the inoculum was removed, cells washed 
with PBS and replaced with media containing 10 µg/ml gentamicin. For samples 
infected at MOI1, cells were spun at 1200 rpm for 3 min to maximize the population of 
infected cells, after which the inoculum was removed, cells washed, and antibiotic-free 
media replaced. At 30 min pi, cells were washed again and 10 µg/ml gentamicin was 
added to inhibit extracellular bacterial replication.  At 8 h pi cells were lysed in buffer 
containing 1% NP-40 on ice for 15 minutes and then spun at 13,000 rpm for 10 min to 
pellet the insoluble fraction. Soluble fractions were separated by SDS-PAGE, transferred 
to nitrocellulose membrane, and probed with anti-caspase-7 antibody. Membranes were 
incubated and treated according to the antibody manufacturer instructions. Membranes 
from individual gels were cut to optimize exposure times for the cleaved and full-length 
forms of the protein. Bands were visualized using West Femto chemiluminescent 
substrate (Thermo Scientific).   
   
Enzyme Activity Assays 
For DEVDase activity assays, 4 million BMDM were plated in a 96 well format and 
infected according to the protocol outlined for immunoblotting. At 8 h pi, cells were 
exposed to the DEVDase substrate per the manufacturer’s instructions (Caspase-Glo 
3/7 Assay; Promega) and enzyme activity was quantified by luminometer.  For LDH 
assays, BMDM were seeded into 96-well plates at a density of 4 million cells per plate. 
Prior to infection, medium was replaced with DMEM lacking phenol red. All 
subsequent steps were performed in this medium. Cells were infected as described 
above and supernatants harvested at indicated times post infection. Lactate 
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dehydrogenase release was quantified using the Cytox96 Assay Kit (Promega) 
according to the manufacturer’s instruction and quantified by spectrophotometer.  
 
Intracellular Growth Assays 
L. monocytogenes growth curves were performed according to the following protocol. 
Sterile glass coverslips were placed in 24 wells, onto which 4 x 106 BMDM were seeded 
and allowed to adhere overnight. Bacteria were added to the BMDM at MOI1 and 
allowed to invade for 30 minutes. The inoculum was then removed, the cells were 
washed three times in PBS, and fresh BMDM media was added with 50 µg/ml 
gentamicin to inhibit extracellular bacterial growth. For gentamicin washout 
experiments, the antibiotic was removed from the cultures 2h pi, and the media was 
replaced every hour to limit the contribution of extracellular bacteria to intracellular 
CFU counts. At the indicated time points, coverslips were removed and BMDM were 
osmotically lysed and serially diluted to enumerate CFU. CFU were counted using the 
aCOLyte SuperCount (Microbiology International, Fredrick, MD) plate reader and 
software.  
 
Immunofluorescence and microscopy 
For TUNEL staining, BMDM were plated in 6-well format at a density of 2 × 106 cells 
per dish and incubated overnight. The cells were then infected according to the protocol 
outlined for immunoblotting and stained for DNA fragmentation per the 
manufacturer’s instructions (Roche).   For host cell permeability assays, BMDM were 
seeded onto square coverslips in 6 well plates at a density of 5 × 105 per well the night 
before infection.  The day of infection, host cells were infected with L. monocytogenes for 
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30 mins, after which the cells were washed 3 times with PBS and cell medium with 10 
µg/ml gentamicin was added. Gentamicin was removed from the medium at 2h pi and 
cells were washed once per hour with fresh media. At 8 h pi, live cells were washed 
twice with HBSS + 30 mM HEPES, and then stained using 1:50 rhodamine-phalloidin 
(Invitrogen) in HBSS + 30 mM HEPES for 15 minutes. Coverslips were rinsed using 
HBSS + 30 mM HEPES and fixed in 4% paraformaldehyde. After fixation, coverslips 
were rinsed three times in TBS + 0.1% Triton-X 100 and counterstained with DAPI. 
Coverslips were mounted onto slides using Prolong Anti-Fade (Invitrogen), and imaged 
at the Center for Live Cell Imaging (CLCI) at the University of Michigan Medical School 
using an Olympus BX60 upright fluorescence microscope (Olympus; Center Valley PA). 
Images were collected using a DP70 CCD color camera (RGB, 12-bits/channel; Olympus 
America Inc., Center Valley PA) using DP70 controller/manager software v3.02.  
Automated image analysis was performed using MetaMorph software (Molecular 
Devices Sunnyvale, CA).  
 
Listeriolysin O expression, purification, and quantification 
For purification of recombinant LLO, 10mL LB cultures containing 50 μg/ml kanamycin 
(LB Kan50) sulfate were inoculated with single colonies of E. coli BL21(DE3) containing 
plasmid pET29 that encodes for a 6xHis-tagged copy of the hly gene encoding 
Listeriolysin O (LLO) from L. monocytogenes strain 10403S from freshly streaked LB agar 
plates and incubated overnight at 37°C with constant agitation. Cultures were then used 
to inoculate 100ml of LB Kan50 and incubated at 30°C with constant agitation for 30 
minutes. IPTG was added to cultures at a final concentration of 1mM and incubation 
was resumed for an additional 18 hto induce LLO expression. Protein expression 
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cultures were pelleted at 4000 x g for 15 min at 4°C and supernatants were discarded. 
Pellets were resuspended in 1ml lysis buffer (50mM sodium phosphate dibasic, 300mM 
sodium chloride, 10mM imidazole; pH 8.0) containing 1 mg/ml lysozyme and 
incubated on ice for 30 minutes. Suspensions were then subjected to 4 x 30 sec 
sonication treatments separated by 15 sec incubation on ice with a Misonix Microson 
Ultrasonic Cell Disruptor XL set to intensity 4. Lysates were centrifuged for 30 minutes 
at 16,000 x g at 4°C.  To purify 6xHis-tagged LLO, a NiNTA spin column (Qiagen, Cat. 
No. 31314) was loaded with 600μl wash buffer (50mM sodium phosphate dibasic, 
300mM sodium chloride, 20mM imidazole; pH 8.0) and centrifuged at 700 x g for 2 
minutes; flow-through was discarded. All subsequent NiNTA spin column 
centrifugation steps were carried out at 700 x g for 2 minutes. Lysate supernatants were 
passed through the column in 600μL increments. Columns were then washed 
sequentially with 600μl volumes of the following: wash buffer, 84% wash buffer / 16% 
glycerol v/v, and wash buffer containing 700mM NaCl. 6XHis-tagged LLO was then 
eluted from the column with two 200μl volumes of wash buffer containing 400mM 
imidazole. Combined elution volumes were then passed through an Amicon Ultra 3000 
MWCO filter unit by centrifugation for 30 minutes at 16,000 x g at 4°C, after which 450μl 
HBSE (10mM HEPES, 140mM NaCl, 1mM EDTA; pH 8.4) buffer was added to the 
column, briefly agitated, and collected by flipping the column and centrifuging the 
solution into a microcentrifuge tube at 16,000 x g for 10 seconds. Protein solutions were 
then separated into 50μl aliquots and stored at – 80°C.  Final protein concentration was 
measured by Bradford assay (Thermo Scientific) using a BSA standard curve.  
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Statistical analysis 
All p values were generated between identified samples using unpaired two-tailed t-
tests and represent analysis of ≥ 3 replicates per condition. * P < 0.05, ** P < 0.01 and *** 
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Transient activation of caspase-7 promotes blebbing and survival in response to 
damage by pore-forming toxins  
(in collaboration with Marie-Ève Charbonneau) 
 
Abstract: The plasma membrane of the mammalian cell is able to withstand damage 
caused by sub-lytic concentrations of pore-forming toxins, but how the membrane 
orchestrates damage control is incompletely understood. Recent work demonstated that 
cells bleb and ectocytose (release or shedding of blebbed vesicles) damaged membrane 
to survive treatment with the cholesterol-dependent cytolysin (CDC) streptolysin O, but 
the molecular mechanisms that license toxin-induced blebbing were not identified. Here 
we report that macrophages treated with the related CDC, listeriolysin O, bleb via a 
mechanism that requires transient activation of the cysteine protease, caspase-7. 
Caspase-7 activation was protective during intoxication, as cells lacking this protease 
displayed altered blebbing, were more permeable to small dyes, and more likely to 
succumb after toxin treatment. Toxin-induced caspase-7 activity contributed to the 
cleavage of ROCK I, a Rho kinase that orchestrates the rearrangement of cytoskeletal 
actin. Inhibition of rho kinases or myosin II, an ATP-dependent motor protein activated 
by ROCK I that coordinates cell contractility, resulted in decreased blebbing in response 
to LLO, and increased susceptibility to intoxication. Therefore, our data support a 
model whereby transient caspase-7 activity orchestrates cytoskeletal remodeling
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 through Rho kinases and myosin II to promote membrane blebbing and increased 
survival in response to pore-forming damage. 
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1. Introduction 
    Membrane damage of host cells is a common hallmark of pathogenesis. Many 
viruses, intracellular bacteria, and parasites must breach the plasma membrane to gain 
access to the intracellular compartment, to egress from the infected cell, or both. 
Extracellular pathogens often secrete membrane-damaging agents, such as pore-
forming toxins, that can elicit a broad range of outcomes for both infectious agent and 
host. The cholesterol-dependent cytolysins (CDCs) are a family of PFTs produced 
primarily by Gram-positive bacteria. CDC monomers oligomerize on target cells to 
form pores capable of allowing the influx of large molecules, such as antibodies, into the 
cytosol [1].  When intoxicated at low concentrations with CDCs, survival of host cells is 
well documented, although at higher concentrations intoxication can results in host cell 
lysis. CDCs have been used for selective permeabilization of cells, and wounds caused 
by CDCs can be rapidly resealed [1-3]. We previously discovered that a cysteine 
protease, caspase-7, was activated in response to PFT damage by various toxins and 
was important for promoting membrane fidelity after this insult [4]. However, the role 
of caspase-7 in promoting membrane integrity is not known. How damaged cells reseal 
the plasma membrane is an active area of investigation, and multiple mechanisms have 
been proposed to explain repair methods.  One such mechanism of promoting barrier 
maintenance after PFT injury is through ectocytosis of damaged sections of membranes 
via the formation of membrane blebs.  
     Membrane blebbing was first characterized as a morphological feature of apoptosis 
[5]. Notably, blebbing is also critical for functions not associated with cell death, such as 
cytokinesis and cell motility [6]. Under resting conditions, the plasma membrane is 
attached to the actin cortical cytoskeleton, which provides rigidity and structure to the 
cell. Blebs are rounded protrusions that occur when the connection between the cortex 
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and the membrane is perturbed. The spherical shape of the bleb depends on cytosolic 
hydrostatic pressure and contraction of the actinomyosin cortex [7], and as such the 
formation of membrane blebs is a tightly regulated event. Much of the information on 
the molecular players that drive blebbing comes from studies on the execution phase of 
apoptosis and the cytoskeletal changes that occur during this process.  
     Blebbing can also promote cell healing and survival after treatment with PFTs. Cells 
blebbed when treated with the CDC, streptolysin O (SLO), and chemical inhibition of 
blebbing sensitized the cells to toxin-induced lysis [8].  By monitoring Ca2+ flux during 
PFT damage, Babiychuck et al suggested that blebbing protected CDC-treated cells by 
sequestering the damaged membrane, which was isolated from the cytoplasm via the 
formation of a plug composed of annexin A1, a membrane-binding Ca2+-sensing 
protein, at the neck of the bleb [8]. SLO-mediated membrane damage also induced bleb 
shedding, or ectocytosis [9,10]. Ectosomes were enriched for SLO compared to the cell 
body [9], which suggests that blebbing and shedding may be a mechanism by which 
cells expel both toxin and damaged membrane. The molecular mechanisms that 
orchestrate blebbing and shedding in response to toxin damage were not determined. 
Based on our previous work which shows that caspase-7 promotes membrane integrity 
after pore-formation [4], we hypothesize that caspase-7 activity may regulate blebbing 
and shedding response to PFT treatment.  
     In this study we determine that intoxication of cells with the CDC listeriolysin O 
(LLO) results in transient activation of caspase-7, which correlates with the recovery of 
membrane integrity after pore-formation. Inhibition of rho-kinases and myosin II also 
decreased blebbing during intoxication and decreased survival rates of intoxicated cells. 
Thus, we have uncovered a mechanism where by the transient activation of an 
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“executioner caspase” directs a signaling cascade that promotes cell survival instead of 
programmed cell death. We speculate that this example of transient activation of 
caspase-7 reflects a broader paradigm of “signal strength”, whereby high levels of 
caspase-7 activity promote programmed cell death, but low-level activation triggers an 
adaptive response resulting in improved cell survival. Thus, the amount of signaling 
sensed provides context to tailor the appropriate cellular response.  
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2. Results 
Caspase-7 is transiently activated and protective in response to damage by pore-
forming toxins 
 We previously demonstrated that primary bone marrow-derived macrophages 
(BMDMs) activate caspase-7 in response to exogenous treatment with purified PFT 
toxin, listeriolysin O (LLO), in the absence of programmed cell death [4]. To address 
how caspase-7 activity could occur in the absence of apoptosis, we questioned whether 
PFT-induced caspase-7 activation was transient, which could explain why programmed 
cell death was not measured under these conditions. We treated RAW 264.7 cells (RAW 
cells) with a sub-lytic concentration (0.3μg/ml) of purified LLO for 1 h. The sub-lytic 
concentration of LLO is defined as the amount at which we measure approximately 10% 
LDH release after 1 h of treatment. After incubation with LLO, cell lysates were 
harvested and probed for the cleavage of caspase-7 via immunoblot using an antibody 
that recognizes both the full length protein and the larger cleavage product (Fig 3.1A). 
We observed cleavage of caspase-7 1 h after toxin treatment, and increased cleavage 
after 2 and 3 h of toxin treatment. To assess the fate of caspase-7 cleavage after toxin 
treatment, we pulsed RAW cells with toxin for 1 h, replaced with fresh media, and 
monitored the cleavage of caspase-7 at the indicated times post toxin pulse. We 
measured the percentage of cleaved caspase-7 in each sample against the total amount 
of signal from each lane of the immunoblot using ImageJ and combined the results from 
three separate experiments (Fig 3.1B).  We found that the abundance of cleaved caspase-
7 increased after 1 h of toxin treatment and that the amount of cleaved protease 
increased when RAW cells were exposed to LLO for longer periods of time (2 or 3 
hours) (Fig 3.1A and B). Interestingly, when we incubated cells with LLO for 1 h, then  
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Figure 3.1 
 
Figure 3.1 Transient caspase-7 activity promotes survival and membrane integrity in 
LLO-intoxicated cells. (A) RAW macrophages were incubated continuously with 0.3 
μg/ml LLO for 1, 2, or 3 h, or for 1 h, washed and allowed to recover in fresh media. 
Cells were then lysed and probed for caspase-7 cleavage and actin. (B) The percentage 
of cleaved caspase-7 in RAW cells using methods as in (A) was measured from the total 
signal in each lane using ImageJ. The graph includes the percentages calculated from 
three separate experiments. P = 0.033. (C) Viability of BMDMs, as measured by the 
metabolic marker WST-1, after 1 h intoxication with 0.25 μg/ml LLO, and the noted 
recovery period. Data were combined from three independent experiments. * P < 0.04 
and ** P = 0.003 using Student’s t-test. (D) Average integrated intensity, as measured by 
Metamorph, of BL/6 and csp7-/- BMDMs incubated with 0.5 μg/ml LLO and rhodamine-
phalliodin (rho-phall) for 15 min. ND = none detected, N > 200 cells, P < 0.0001 by 
Student’s t-test. Error bars are SEM. (E) Rhodamine-phalloidin permeability after 1 h 
exposure to 0.25 μg/ml LLO, and replacement with fresh media. N < 130 and P < 0.0004 
for each condition by Students’ t-test. (D, E) are representative of three independent 
experiments.  (A-C and E) were performed and analyzed by MEC.    
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we consistently saw an increase in signal over 1 h treatment alone that decreased 2 h 
after toxin removal (Fig 3.1A and B). Similarly, we saw transient caspase-7 activation 
when we pulsed BMDMs with sub-lytic LLO (0.25μg/ml) for 1 h and monitored the 
abundance of caspase-7 cleavage over time (Fig. A8). We considered the possibility that 
loss of cleaved caspase signal over time could be due to death of cells in which caspase-
7 was activated. However, the amount of actin present in the cell lysates was equal over 
time, which is inconsistent with the hypothesis that cell loss was responsible for the loss 
of caspase-7 cleavage signal. Instead, these results suggest that caspase-7 is transiently 
activated in RAW cells and BMDMs in response to PFT treatment.  
     To determine if the activation of caspase-7 was promoting survival of intoxicated 
cells, we pulsed either BL/6 or csp7-/- BMDMs with a sub-lytic concentration of LLO for 
1 h, removed the toxin and replaced with fresh medium and monitored the viability of 
cells over time using the tetrazolium salt WST-1. WST-1 is reduced to a dye, formazan, 
by a mechanism that depends on the production of NAD(P)H in viable cells. Therefore, 
the amount of formazan dye formed from WST-1 directly correlates with the metabolic 
state of the cell culture. When compared to untreated cells, we measured a 15% 
decrease in formazan conversion in BL/6 cells 2 h after LLO was removed from the 
culture media (Fig 3.1C). However, at 3 and 5 h after toxin removal, formazan 
conversion was near untreated levels (mean of 92% and 95% respectively) (Fig 3.1C). 
Using our experimental conditions, BMDMs are not likely to divide significantly in the 
tested time period. Therefore, we hypothesize that cell division is not responsible for 
the increase in viability we see at 3 and 5 h compared to 2 h post intoxication. More 
likely, intoxication induces partial and transient metabolic quiescence, which has been 
documented for LLO intoxication by others [11]. When csp7-/- cells were exposed to the 
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same concentration of LLO for 1 h, we observed a much sharper decrease (mean 52%) in 
metabolic activity 2 h after toxin removal (Fig 3.1C). LLO-treated csp7-/- cells displayed 
significantly lower metabolic activity compared to BL/6 BMDMs at all times measured 
(Fig 3.1C). We measured no difference in the metabolic activity of untreated csp7-/- and 
BL/6 cells.  These data indicate that the csp7-/- macrophages are more sensitive to LLO 
treatment, and less able to recover post-intoxication.  
     Previously we demonstrated that macrophages isolated from csp7-/- mice were more 
permeable to small molecules during infection with Listeria monocytogenes compared to 
BL/6 macrophages [4]. However, whether csp7-/- macrophages were more permeable 
during LLO intoxication was not determined. To address this, we treated BL/6 and  
csp7-/- macrophages with LLO and assessed their permeability to the small fluorescent 
dye, rhodamine-phalloidin (rho-phall), for 15 minutes. Phalloidin is cell impermeant, 
but if the plasma membrane barrier is disrupted, it can diffuse into the cell and 
irreversibly bind to filamentous actin. We measured the amount of rho-phall that 
diffused into the cells during a 15 min treatment with LLO using quantitative 
Metamorph software analysis of fluorescent micrographs. We discovered that the csp7-/- 
cells allowed more rho-phall into the cytosol during our 15 min toxin incubation 
compared to the BL/6 cells (Fig 3.1D). We also wanted to determine how long after 
toxin treatment these cells would remain sensitive to phalloidin influx. To test this, we 
treated cells with LLO for 1 h, removed the toxin and replaced with fresh media, and 
then stained with phalloidin at varying times after toxin removal. We found that the 
csp7-/- allowed more phalloidin into the cytosol after 2 and 3 post intoxication compared 
to BL/6 cells (Fig 3.1E and Fig A9). This result, combined with Fig 3.1D, suggests that 
caspase-7 deficiency allows increased initial permeability in response to LLO treatment, 
and delays the ability of cells to become refractory to small molecule influx. Together, 
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these results suggest that transient activation of caspase-7 promotes cell integrity after 
PFT damage.    
 
LLO damage stimulates rapid blebbing mediated by caspase-7  
     Our previous results suggested that caspase-7 plays a role in damage control in 
response to treatment with LLO. To determine if there exist differences in the way csp7-/- 
and BL/6 BMDMs physically respond to treatment with exogenous LLO, we used live 
cell imaging to monitor the behavior of intoxicated cells over time. We included in the 
medium a cell impermeant fluorescent marker, SYTOX green, which upon binding 
nucleic acids increases in fluorescence >500 fold, as an indicator of when cells first 
experience membrane damage.  We observed that BL/6 BMDMs treated with sub-lytic 
LLO rapidly blebbed (solid arrows) and ectocytosed (solid arrowhead) after becoming 
permeable, as measured by SYTOX green positivity (Fig 3.2A). These results are 
consistent with the results of others who have used a related CDC, SLO, to studying 
blebbing and ectocytosis in response to toxin-derived damage [8,9]. We observed that 
the blebs that formed on the membrane were highly dynamic; some blebs resolved 
quickly, while others continued to grow throughout the time course of the experiment 
(see the third and fourth panels of Fig 3.2A). Every BL/6 BMDM monitored using live 
cell imaging blebbed in response to toxin treatment. The amount of time between 
membrane breach (as measured by SYTOX positivity) and first bleb was consistent 
among cells (average ~180 sec) (Fig 3.2C). When we monitored the response to toxin in 
the csp7-/- cells, however, we observed very different behavior. The csp7-/- cells became 
initially permeable after the addition of toxin with similar kinetics to BL/6 cells. 
However, they were far less likely to bleb; only 40% csp7-/- cells blebbed within 30  
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Figure 3.2 
 
Figure 3.2. Csp7-/- cells display altered blebbing compared to BL/6 cells in response to 
LLO treatment. (A) and (B) Micrographs were taken at time 0 before addition of LLO 
(far left panels). LLO was added at a working concentration of 0.1μg/ml and cells were 
monitored for 30 min after becoming SYTOX positive. Arrowheads denotes shedding, 
solid arrows denote blebbing, and double-headed arrows denote swelling. Scale bar = 
10μm. (C) The amount for time between SYTOX positivity and first bleb. Csp7-/- cells that 
failed to bleb within 30 min of becoming permable are denoted on the graph in open 
squares and were not included in statistical analysis. All BL/6 cells blebbed in response 
to toxin. N=10 for BL/6 and N=10 for csp7-/-, combining data from at least 5 separate live 
cell imaging experiments. *** P = 0.0003 using Students unpaired t-test.   
minutes of becoming SYTOX positive, whereas 100% BL/6 cells blebbed within this  
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time frame (Fig 3.2C).  Csp7-/- cells that did not bleb often swelled after becoming 
SYTOX positive (double-headed arrows), possibly indicative of unresolved membrane 
damage (Fig 3.2B). Of the csp7-/- cells that did bleb in response to toxin, they did so with 
much slower kinetics than the BL/6 cells. The average time between permeability to 
blebbing of the 4 csp7-/- cells that blebbed was an average of ~600 sec, three times longer 
than the BL/6 cells (Fig 3.2C).  These results demonstrate that, upon PFT-mediated 
damage, caspase-7 deficiency perturbs blebbing, which correlates with decreased 
membrane integrity and cell survival post intoxication.  
 
ROCK I is activated by PFT damage in a caspase-dependent manner 
     To determine the mechanism by which caspase-7 promotes blebbing during 
intoxication, we questioned whether toxin-induced blebbing and apoptotic blebbing 
could be controlled by similar mechanisms.   During apoptosis, a rho-associated kinase, 
ROCK I, drives blebbing in a caspase-dependent manner [12,13]. Caspase-3 activity was 
required to cleave the kinase, an irreversible activation event. To determine if Rho-
kinases were also important for blebbing in response to toxin damage, we monitored 
the cleavage of ROCK I in RAW cells via immunoblot after sub-lytic intoxication with 
LLO. Treatment with TNFα and cyclohexamide was used as a positive control for 
ROCK I cleavage.  We were able to detect cleavage after 2 and 3 h of intoxication with 
LLO (Fig 3.3 top panel). To determine if ROCK I activation was mediated by caspases 
during PFT damage, we pre-treated RAW cells with a caspase-3/7 inhibitor, DEVD-
fmk, which irreversibly binds the active form of these enzymes. Therefore, treatment 
with DEVD-fmk will not inhibit caspase-3/7 cleavage, but will inhibit their proteolytic  
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Figure 3.3 
 
Figure 3.3. ROCK I is cleaved in a caspase-dependent manner in response to LLO 
damage.  RAW cells were pre-incubated for 1 h with or without 100 μM DEVD-fmk and 
then intoxicated for two or three hours with 0.3 μg/ml LLO.  Cells were lysed and 
probed for ROCK I, caspase-7, and actin via immunoblot. This blot is representative of 
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ability once cleaved. When DEVD-fmk was added to the cell media, ROCK I cleavage 
was no longer detected at 2h post intoxication (Fig 3.3), indicating that caspase-3/7 
potentiate ROCK I cleavage in response to LLO treatment. We did, however, detect 
ROCK I cleavage at 3 h post intoxication, indicating that caspase-3/7 are not alone in 
their ability to activate ROCK I during intoxication, or that inhibition with DEVD-fmk is 
not complete (Fig 3.3). As expected, DEVD-fmk did not inhibit caspase-7 activation; 
instead a subtle size shift in the cleavage band compared to untreated lanes suggests the 
inhibitor did, in fact, bind the active caspase (Fig 3.3). This result demonstrates that 
ROCK I is cleaved in response to toxin and suggests that caspases are important in 
directing ROCK I cleavage.  
     ROCK I controls cytoskeletal contractility, and thus blebbing, through its regulation 
of myosin light chain (MLC). During apoptotic blebbing, Sebbagh et al demonstrated 
that caspase-3 cleavage of ROCK I was required for activation of MLC [12]. Therefore it 
is possible that caspase-7 directed ROCK I activation also activates MLC during toxin-
induced blebbing.  
 
Inhibition of Rho-kinases and MLC prevent blebbing in response to PFT damage 
     Since ROCK I activity is critical for blebbing in response to apoptotic stimuli, we 
tested whether Rho-kinase inhibition would limit blebbing in response to PFT damage. 
We pre-treated BMDMs with Y-27632 (Y27), a chemical inhibitor selective for both 
isoforms of ROCK (ROCK I and ROCK II) [14,15] and then monitored their ability to 
bleb after LLO intoxication using live cell imaging. We found that Rho-kinase inhibition 
significantly blunted BMDMs blebbing post intoxication (Fig 3.4A). Only 50% cells 
treated with Y27 blebbed after toxin treatment, and those that did blebbed with delayed 
kinetics after becoming permeable compared to mock treated BMDMs (Fig3.4C and D).  
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Figure 3.4 
 
Figure 3.4. Inhibition of ROCK and myosin impedes toxin-induced blebbing. (A,B) 
Cells were treated with 10 μM Y-27632 (Y27) for 2 hours (A) or 50μM blebbistatin 
(blebb) for 30 minutes (B) before visualization. Micrographs were taken at time 0 (far 
left) before addition of LLO at a working concentration of 0.1μg/ml. Cells were 
monitored for 30 min after becoming SYTOX positive. Solid arrowheads denote 
shedding and or unsuccessful blebbing, double-headed arrows denote swelling. Scale 
bar = 10μm. (C) The amount of time between SYTOX positivity and first bleb. Cells that 
failed to bleb within 30 min of becoming permable are denoted on the graph in open 
symbols and were not included in statistical analysis. All BL/6 cells blebbed in response 
to toxin. N=10 for BL/6, N=9 for Y27-treated, and N=7 for blebb-treated, combining 
data from at least 4 separate live cell imaging experiments. (D) Permeability to rho-phall 
during 15 min 0.5μg/ml toxin treatment as assessed by Metamorph software. N>200 for 
each condition, representative of at least 3 independent experiments. (C,D) Error bars 
depict SD, P≤0.0001 for each condition compared to mock using Students’ t-test.     
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These results suggest that Rho-kinases promote blebbing in response to PFT damage.      
 
     To determine if the proposed target of ROCK activity, myosin light chain (MLC), 
could also direct toxin-induced blebbing, we treated cells with a small molecule 
inhibitor specific for myosin II, blebbistatin [16,17], and assessed blebbing after toxin 
treatment using live cell imaging. Blebbistatin treatment significantly impaired the 
ability of cells to bleb and prolonged the time between membrane damage and 
blebbing, similarly to Y27 treatment and csp7-/- deficiency (Fig 3.4B,C and D). Together 
these data suggest that Rho-kinases and myosin II contribute to the blebbing response 
after LLO-mediated damage.   
     To determine if inhibition of blebbing altered the ability of cells to withstand influx 
of small molecules during toxin damage, we pretreated cells with either Y27 or blebb 
and then incubated with LLO and rho-phall for 15 min. We quantified the intensity of 
rho-phall staining from fluorescent micrographs using Metamorph software. We found 
that inhibition of Rho-kinases and myosin II significantly increased the permeability of 
LLO intoxicated cells (Fig 3.4E). Inhibitors alone had no effect on permeability to rho-
phall independent from toxin treatment (Fig 3.4E). Together, these results suggest that 
Rho-kinases and myosin II contribute to blebbing and membrane integrity in response 
to LLO-mediated damage. 
 
Caspase-7 deficiency reduces annexin A1 aggregation in response to LLO 
     Blebbing in response to PFT damage has been proposed to promote the survival of 
intoxicated cells [8]. Babiychuk et al hypothesized that blebbing promoted survival by 
sequestering damaged membrane and separating the lesion from the cell body via the 
formation of a plug composed of the calcium-binding protein annexin A1 (anxA1) [8]. 
To determine whether the distribution of anxA1 was altered by absence of caspase-7 in 
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BMDMs in response to LLO, we intoxicated cells with 0.25μg/ml LLO for 1 h and then 
stained cells with a monoclonal antibody against anxA1. In un-intoxicated cells, we 
found the distribution of anxA1 staining was diffuse throughout the cytosol (Fig 3.5A). 
After 1 h of LLO treatment, most of the staining remained diffuse. However, we also 
noticed some aggregation of anxA1 into distinct ring-like structures in 12% of cells (Fig 
3.5A and C). Given our data which suggest that most cells are permeable and bleb after 
this treatment with LLO (Fig 3.1 and Fig 3.2), we hypothesize that fixation and staining 
damages the relatively fragile blebs, and therefore, we are likely underscoring the 
incidence of AnxA1 aggregation due to experimental limitations. However, when we 
scored for the formation of anxA1 rings in the csp7-/- cells, we counted significantly 
fewer rings (Fig3.5B and C), supporting our previous data that suggest csp7-/- cells bleb 
less than BL/6 (Fig 3.2). Therefore, we conclude that anxA1 aggregation in response to 
LLO treatment is reduced in absence of caspase-7.  
 
Rho-kinases and myosin II promote cell integrity during infection  
     Our data establish a critical role for caspase-7, Rho-kinases, and myosin II in 
blebbing and survival upon damage by exogenous LLO. To assess whether this axis 
was important during infection with the bacterium that secretes LLO, Listeria 
monocytogenes, we infected BL/6 BMDMs at MOI 1 and allowed the infection to 
progress for 7.5 hours. We then added either Y27 or blebb to the cell media and 
incubated for an additional 30 min, after which we stained with rho-phall and scored 
the permeability of infected cells. Rho-kinase or myosin II inhibition significantly 
increased the permeability of infected cells to small molecules (Fig 3.6A). This suggests 
that Rho-kinases and myosin II promote cell integrity during infection with L.  
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Figure 3.5 
 
Figure 3.5. Annexin A1 aggregation is reduced in csp7-/- BMDMs post intoxication. 
(A, B) BMDMs were incubated with 0.25ug/ml LLO for 1 h, after which the cells were 
fixed and probed with antibody specific for annexin A1 (anxA1) (Santa Cruz SC-1923-
R). Cells were scored of the presence of anxA1 ring-like structures on their surface (see 
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monocytogenes. To determine if ROCK I cleavage could be detected during L. 
monocytogenes infection, we infected RAW cells at an MOI 5 for 12 h and probed for both 
caspase-7 and ROCK I. We found that both proteins were activated under this condition 
(Fig 3.6B). However, infection with a strain of L. monocytogenes with a genetic deletion 
for hly, the gene that encodes LLO (LLO-), did not result in either caspase-7 or ROCK I 
cleavage (Fig 3.6B). To further implicate the importance of LLO in this cellular response, 
we infected with a strain of L. monocytogenes that expresses a mutant LLO protein 
previously reported to oligomerize with faster kinetics than endogenous LLO (L461T) 
[18,19]. We found that infection with this strain of bacteria increased the percentage of 
cleaved ROCK I compared to WT L. monocytogenes infection (Fig 3.6B) Taken together, 
these results suggest that cells activate caspase-7, ROCK I, and myosin II to promote cell 
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Figure 3.6 
 
Figure 3.6. ROCK I and myosin II promote membrane fidelity during infection with 
L. monocytogenes. (A) BMDMs were infected at an MOI1 for 7.5 hours, after which 
10μM Y-27632 or 50μM blebbistatin was added to the cell culture and incubated for an 
additional 30 min. At 8 h pi, cells were incubated with rho-phall and the total number of 
phall positive cells was assessed. Error bars represent SEM, N > 200/condition, P < 
0.0004 by Student’s t-test, representative of two independent experiments. (B) RAW 
cells were infected at MOI5 with WT, LLO-, or L461T L. monocytogenes for 12 h, after 
which lysates were collected for immunoblot and probed for ROCK I, caspase-7, and 
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3. Discussion 
     Here we find that treatment of cells with a PFT, LLO, induced blebbing in primary 
bone marrow derived macrophages and RAW 264.7 cells. Blebbing was mediated by 
caspase-7, which was transiently activated in response to LLO intoxication. 
Macrophages deficient in caspase-7 displayed profoundly altered blebbing: They 
blebbed less frequently, and blebbing was delayed compared to wild-type cells. 
Inability to properly bleb correlated with increased permeability to small molecules and 
decreased survival in response to toxin as measured by mitochondrial respiration.  
Macrophages from caspase-7 knock out mice were deficient in their ability to activate 
the rho kinase ROCK I in response to toxin treatment. Chemical inhibitors of Rho-
kinases and myosin II displayed decreased toxin-induced blebbing and decreased 
survival post toxin treatment. These results suggest a model whereby PFT-induced 
damage transiently activates a caspase-7/Rho-kinase/myosin II axis to promote 
blebbing and survival of PFT-treated cells.      
     Members of the rho family of GTPases are signal transducing molecules and key 
regulators of the actin cytoskeleton [20]. A downstream effector activated by rho-
GTPases is rho-associated kinase I, or ROCK I, which promotes cytoskeletal contractility 
through its regulation of myosin light chain (MLC). ROCK I activates MLC through at 
least two distinct mechanisms; direct phosphorylation [21], and through 
phosphorylation of MLC phosphatase, which promotes the constitutive activity of MLC 
[22,23]. ROCK I activation of MLC was necessary for the formation of blebs during the 
execution phase of apoptosis [12]. Notably, caspase-3 was responsible for the cleavage 
and irreversible activation of ROCK I under this condition, and chemical inhibition of 
caspase-3/7 or rho-kinases eliminated blebbing in response to apoptotic stimuli [12,13]. 
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Thus, caspase-mediated signaling can direct the cytoskeletal rearrangement necessary 
to drive bleb formation during apoptosis.            
     Transient caspase activation can occur during cell differentiation. Transient caspase-3 
activation was required for the differentiation of skeletal muscle myoblasts [24], and has 
been implied for other long-lived cell types, such as osteoblasts and neurons [25,26]. 
Caspase-3 is also necessary for the differentiation of embryonic stem cells [27] and 
hematopoietic cells [28]. However, the kinetics of caspase-3 inactivation was not 
addressed in these examples. To our knowledge, this is the first report of transient 
caspase-7 activation in differentiated cells.  
     Perhaps not surprisingly, the relative abundance of activated caspase-7 in response 
to sub-lytic LLO is low. The cleavage of caspase-7 increases with the amount of LLO 
introduced, as does the amount of LDH released (Chapter 2 and [4]), which suggests 
that the amount of cleaved caspase-7 may direct the fate of the affected cell.  Low-level 
caspase-7 activation may promote cell survival by activating blebbing in response to 
toxin damage for example; but, increasing the amount of cleaved caspase-7 may shunt 
the cell into programmed cell death. An alternative hypothesis is that increased damage 
activates caspase-3, which then drives the cell into apoptosis.  
     Another method by which caspase-7 could control multiple and divergent cellular 
outcomes is through subcellular localization of the protease. Caspase-7 is a cytosolic 
protein [29], but there are published reports that  link caspase-7 to particular subcellular 
compartments. For instance, caspase-7 may associate with the ER [30-33] (discussed in 
more detail below). Caspase-7 may also associate with the inflammasome [34,35]. 
Importantly, caspase-7 is found within TNFα multivesicular bodies [36], suggesting that 
some caspase-7 protein could be in close proximity to the plasma membrane. It is 
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attractive to speculate that the location of activated caspase-7 dictates the signal cascade 
activated. For instance, caspase-7 cleaved at the cell membrane could activate blebbing 
and survival in response to pore-formation. Localization would also allow for maximal 
proteolytic capacity from a relatively low abundance of active protein. We have not yet 
identified the subcellular location of caspase-7 activated by PFT damage. Additionally, 
it remains unclear how caspase-7 is activated in response to toxin.  
     Several reports link caspase-7 activation with the ER [30-33] and cellular calcium. 
Calpain, a Ca2+ sensing protease, can cleave and activate caspase-7 [37], and CDCs are 
well documented as causing Ca2+ flux in the cell [2,3,38,39]. Ca2+ sensing may be 
responsible for membrane blebbing and repair. We have preliminary results that 
suggest Ca2+ depletion inhibits blebbing and activates caspase-7 (data not shown), and 
others have shown that Ca2+ is necessary for repair [2,40]. Therefore, Ca2+ signaling is 
likely important for the activation of caspase-7 in this model, and may account for the 
caspase-7-dependent protective response after toxin damage.  
     Membrane damage is not confined to pathogenesis. For instance, cells that encounter 
mechanical stress, such as the gastrointestinal epithelium, display wounding and repair 
in vivo [41]. Membrane damage can also arise as an outcome of pathology. Amyloid 
proteins, which are involved in Alzheimer’s disease, are known to perforate the plasma 
membrane [42-46]. The antinuclear antibodies generated as a result of autoimmunity 
are suggestive of chronic, irreparable membrane damage [47]. Indeed, mice deficient in 
lysosomal proteins responsible for resealing membrane lesions display autoimmune 
symptoms [48], highlighting the importance of quotidian barrier vigilance and fidelity. 
     The mammalian immune system also displays pore-forming capacity. For instance, 
cytotoxic T cells use a pore-forming protein, perforin, to introduce lethal granzyme into 
virus-infected and transformed cells [49]. Recent work suggests the pore produced by 
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perforin is rapidly resealed after granzyme delivery [50] similar to the rapid resealing of 
CDC pores [2,3], perhaps suggestive of shared repair mechanisms. This also suggests 
that cells may be able to withstand damage by physiological concentrations of perforin 
in the absence of proteolytic granzymes. Importantly, perforin and granulysin can 
activate caspase-7 and damage the ER [51]. Therefore, the mechanism that protects cells 
from bacterial PFTs may also protect from unintended perforin deposition in the 
absence of granzyme delivery.  
     We previously demonstrated that the caspase-7 is activated by membrane damage 
caused by PFTs, but not detergent [4], conferring specificity to the caspase-7-dependent 
cytoprotective response. Specificity may be achieved by the sensing of concentrated ion 
fluxes, such as a Ca2+ gradient, across the damaged membrane. Ca2+ sensing is the 
mechanism proposed by other groups for the recruitment of lysosomes and anxA1 to 
damaged membrane [8,40].  Detergents can selectively permeabilize host cells in the 
absence of overt cell death [52], which suggests that the cell uses different mechanisms 
to reseal the membrane in response to different types of membrane damage. Therefore, 
concentrated ion flux may be the mechanism by which cells can differentiate between 
acute and diffuse membrane damage, whereby acute damage may stimulate an 
adaptive repair mechanism. Given the ubiquity of membrane damage, we propose that 
cells activate a molecular signaling cascade in response to PFT damage that relies on 
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4. Materials and Methods 
Bacterial Strains and Reagents 
BMDM and RAW 264.7 cells were infected with Listeria monocytogenes strain 10403S 
(WT), DP-L2161 (LLO-) [53] which has an in-frame deletion of the hly gene, and L461T 
[18] which has an in-frame deletion of the hly gene replaced with an allele that has an 
amino acid substitution at position 461.  The anti-caspase-7 antibody, which recognizes 
full length and cleaved caspase-7 (cat #9492) was purchased from Cell Signaling 
Technology, anti-ROCK I (cat #611136) was purchased from BD Transduction 
Laboratories, anti-annexin A1 (cat #sc-1923-R) was purchased from Santa Cruz 
Biotechnology, Inc and anti-actin (cat #MS1295P1) was purchased from Fisher Scientific. 
Rhodamine-phalloidin (cat #R415) and SYTOX Green (cat #S7020) were purchased from 
Molecular Probes. WST-1 (cat #11644807001) was purchased from Roche Molecular 
Biochemicals. Y-27632 (cat #1254) was purchased from Tocris Bioscience and 
blebbistatin (cat #BML-EI15) was purchased from Enzo Life Sciences.  
 
Cell Culture and Infection 
Bone marrow derived macrophages (BMDM) were isolated from WT C57BL/6 mice 
and/or csp7-/- mice in a C57BL/6 background. Mice were bred at Jackson Laboratories 
(Bar Harbor, ME) and sacrificed on-site. Leg bones were isolated and shipped overnight 
on ice to the University of Michigan, where the marrow was harvested the next 
morning.  Briefly, isolated BMDM were differentiated in DMEM with 20% heat-
inactivated FBS (Hyclone Laboratories or Gibco), 1% L-glutamine, 1% sodium pyruvate 
and 30% L929 fibroblast conditioned medium.  Cells were cultured in non-TC treated 
plates, fed with fresh mediim on day 3 and harvested on day 6 for infection on day 7. 
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Cultures were maintained in a humidified incubator at 37°C with 5% CO2. Overnight 
cultures of L. monocytogenes in BHI broth were incubated statically at 30°C. Prior to 
infection, bacteria were pelleted and resuspended in PBS.  
 
Immunoblots 
Four million BMDM were plated in 6 well plates 18 hprior to infection. Cells were 
incubated with LLO or infected with bacteria for the stated time in complete cell 
medium. Cells were lysed in buffer containing 1% NP-40 on ice for 15 minutes and then 
spun at 13,000 rpm for 10 min to pellet the insoluble fraction. Soluble fractions were 
separated by SDS-PAGE, transferred to nitrocellulose membrane, and probed with 
antibody. Membranes were incubated and treated according to the antibody 
manufacturer instructions. For caspase-7 cleavage in BMDMs, membranes from 
individual gels were cut to optimize exposure times for the cleaved and full-length 
forms of the protein. Bands were visualized using either tetramethylbenzidine (TMB) 
(Sigma) or West Femto chemiluminescent substrate (Thermo Scientific).  
 
Cell Viability Assay 
Two and a half million BMDMs were plated in a 24-well format and intoxicated with a 
final concentration of LLO 0.25 μg/ml for 1 h. Toxin buffer alone was added to control 
wells. Cells were washed twice with PBS, and fresh medium was added. WST-1 reagent 
was diluted 1 in 10 in cell medium and added to wells at the given times post-
intoxication. The OD440nm was determined 90 minutes after addition of WST-1 and 
normalized to the buffer treated cells to obtain the percent viable cells in a given 
experimental condition.    
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Fixed cell microscopy 
For host cell permeability assays in response to LLO treatment, BMDM or RAW cells 
were seeded onto square coverslips in 6 well plates at a density of 5 × 105 per well the 
night before infection.  The day of infection, host cells were incubated with either 
0.5μg/ml LLO and 1:50 rho-phall in cell medium for 15 minutes, or 0.25μg/ml for 
BMDM or 0.3μg/ml for RAW cells for 1 h, after which 1:50 rho-phall was added in cell 
medium for 15 min. Otherwise, cells were allowed to recover in cell medium for the 
given times and then incubated with 1:50 rho-phall for 15min. For host cell permeability 
during infection, cells were then washed 3 times with PBS and fixed in 4% 
paraformaldehyde. After fixation, coverslips were rinsed three times in TBS + 0.1% 
Triton-X 100 and counterstained with DAPI. For host cell permeability during infection, 
cells were infected with L. monocytogenes at MOI1 and spun for 3 min at 1200 rpm to 
maximize bacterial-host cell contact. After spinning the inoculum was removed and 
replaced with fresh medium. After 30 min, 10µg/ml gentamicin was added to kill any 
extracellular bacteria. Gentamicin was removed from the medium at 2h pi and cells 
were washed once per hour with fresh media. At 8 h pi, live cells were stained using 
1:50 rho-phall for 15 minutes, rinsed with PBS, and fixed in 4% paraformaldehyde.  For 
anxA1 staining, BMDMs were incubated in 0.25μg/ml for 1 h then fixed in 4% 
paraformaldehyde. After fixation cells were rinse in TBS + 0.1% Tx-100 (TBS-Tx) and 
blocked in 1% BSA for 10 min. Anti-AnxA1 was added at 1:500 for 1 h. For all 
fluorescence microscopy experiments, cells were counterstained with DAPI. Coverslips 
were mounted onto slides using Prolong Anti-Fade (Invitrogen), and imaged at the 
Center for Live Cell Imaging (CLCI) at the University of Michigan Medical School using 
an Olympus BX60 upright fluorescence microscope (Olympus; Center Valley PA). 
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Images were collected using a DP70 CCD color camera (RGB, 12-bits/channel; Olympus 
America Inc., Center Valley PA) using DP70 controller/manager software v3.02. 
Micrographs of a minimum of 200 cells were analyzed per experiment and automated 
analysis of rho-phall intensity was quantified using Metamorph v7.7 software 
(Molecular Devices, Downingtown PA).    
 
Live cell imaging 
BMDMs were plated at a concentration of 1.5 x 105 onto 35mm glass bottom petri dishes 
(cat #P35G-0-10-C, Matek Corp.) and allowed to adhere overnight. Before visualization 
the overnight medium was removed and replaced with LCI medium (DMEM lacking 
phenol red, + 25mM HEPES + 500nM SYTOX Green). Microscopy experiments were 
performed in the Center for Live Cell Imaging (CLCI) at the University of Michigan 
Medical School using an Olympus IX70 inverted microscope (Olympus; Center Valley 
PA). Illumination was provided from a 100W halogen lamp for phase-contrast 
microscopy and by an X-Cite 120 metal halide light source (EXFO; Mississauga, ON, 
Canada) for fluorescent microscopy using a 100X (oil immersion; UPlan Fl, NA=1.30) 
objective. Images were collected using a CoolSNAP HQ2 14-bit CCD camera 
(Photometrics; Tucson AZ).  All devices were controlled through Metamorph Premier 
v6.3 software (Molecular Devices, Downingtown PA). Analysis of the imaging data, 
including the preparation of image overlays, montages and movies, was performed 
using Metamorph v7.7 software.  Micrographs for phase contrast and SYTOX 
(excitation 492nm/BP18, emission 535nm/BP40) were taken before the addition of LLO 
at a working concentration 0.1µg/ml, after which micrographs were taken every 30 
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secs. Cells were monitored for SYTOX positivity, after which micrographs were 
collected for an additional 30 min.        
 
Listeriolysin O expression, purification, and quantification 
For purification of recombinant LLO, 10mL LB cultures containing 50μg/ml kanamycin 
(LB Kan50) sulfate were inoculated with single colonies of E. coli BL21(DE3) containing 
plasmid pET29 that encodes for a 6xHis-tagged copy of the hly gene encoding 
Listeriolysin O (LLO) from L. monocytogenes strain 10403S from freshly streaked LB agar 
plates and incubated overnight at 37°C with constant agitation. Cultures were then used 
to inoculate 125 ml of LB Kan50 and incubated at 30°C with constant agitation for 2 h. 
IPTG was added to cultures at a final concentration of 1mM and incubation was 
resumed for an additional 5 h to induce LLO expression. Protein expression cultures 
were pelleted at 4000 x g for 15 min at 4°C and supernatants were discarded. Pellets 
were then stored at -80°C overnight. The next morning, pellets were resuspended in 
1.3ml Buffer A (50mM sodium phosphate buffer pH 8.0, 1M sodium chloride, 5mM 
mercaptoethanol, 10mM imidazole, and 1 mini-complete protease inhibitor tablet 
(Roche)) containing 1mg/ml lysozyme and 0.75mg/ml DNase1. Suspensions were then 
subjected to 4 x 30 sec sonication treatments separated by 15 sec incubation on ice with 
a Misonix Microson Ultrasonic Cell Disruptor XL set to intensity 4. Lysates were 
centrifuged for 30 min at 16,000 x g at 4°C.  To purify 6xHis-tagged LLO, a NiNTA spin 
column (Qiagen, Cat. No. 31314) was loaded with 600μl Buffer A and centrifuged at 700 
x g for 2 minutes; flow-through was discarded. Lysate supernatants were passed 
through the column in 600μL increments and spun at 1600 rpms for 5 min. All 
subsequent NiNTA spin column centrifugation steps were carried out at 700 x g for 2 
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min.  Columns were washed sequentially with 600μl volumes of the following: 3 times 
with Buffer B (50mM sodium phosphate buffer pH 8.0, 1M sodium chloride, 5mM 
mercaptoethanol, 20mM imidazole) and 2 times with Buffer C (50mM sodium 
phosphate buffer pH 6.0, 1M sodium chloride, 5mM mercaptoethanol, 20mM imidazole, 
0.1% Tween-20, 10% glycerol). 6XHis-tagged LLO was then eluted from the column 
with 200μl elution buffer (50mM sodium phosphate buffer pH 6.0, 1M sodium chloride, 
5mM mercaptoethanol, 500mM imidazole). Eluted samples were then dialyzed 
overnight in 1L dialysis buffer (50mM sodium phosphate buffer pH 6.0, 500mM sodium 
chloride, 1mM EDTA, 170μM TCEP) using Tube-O-DIALYZERs with a MW cutoff of 
15,000 Da (cat #786-618 GBiosciences). The next morning, samples were washed with 1L 
fresh dialysis buffer for an additional 4 h at 4°C.  Protein solutions were then separated 
into 10μl aliquots and stored at – 80°C. Final protein concentration was measured by 
Bradford assay (Thermo Scientific) using a BSA standard curve and activity was 
measured by hemolysis of sheep red blood cells.  
 
Statistical analysis 
All p values were generated between identified samples using unpaired two-tailed t-
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Chapter 4 
The contribution of cellular processes to membrane repair after LLO damage 
 
1. Introduction 
      We successfully identified some molecular constituents responsible for driving 
blebbing and promoting membrane integrity in response to LLO-mediated membrane 
damage. However the cell may employ multiple mechanisms to ameliorate membrane 
injury. For instance, we hypothesize that damaged sections of membrane are 
sequestered into blebs and then shed as vesicles from the cell body. This implies that the 
damaged and shed membrane must be replaced to maintain cellular shape and 
homeostasis. Cell surface area may be maintained after injury by co-opting internal 
sources of membrane to patch the plasma membrane. This method of membrane repair 
has been reported in the context of PFT-derived, infection-associated, and scratch 
wound damage [1-3]. Another method by which membrane maintenance can be 
achieved after injury is by the generation of new membrane de novo. Lipid synthesis was 
shown to ameliorate membrane damage by chemical and electrical injury, as well as 
PFT injury [4-6]. This chapter will discuss some experiments which aim to identify 
whether cells recruit internal membrane to the surface to patch PFT-damaged lesions 
and whether the cell upregulates lipid synthesis to make new membrane. Some of 
experiments outlined here will also attempt to tie in data from previous chapters 
identifying causes for defective repair in the context of caspase and blebbing 
deficiencies.  
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2. Results 
Lysosomal exocytosis as a possible repair mechanism for LLO-mediated damage 
Research in Norma Andrews’ lab has elegantly described a mechanism of membrane 
healing that requires the exocytosis of lysosomes to the cell surface in response to 
scratch wounds and the PFT streptolysin O. One of the seminal papers describing this 
repair mechanism shows relocalization of a lysosomal surface protein, LAMP-1, to the 
plasma membrane after injury [1]. To test whether this repair mechanism might also 
occur during infection with L. monocytogenes, we infected BMDMs at MOI 1 for 8 h and 
then incubated the cells with an anti-LAMP-1 antibody, in the absence of 
permeabilization. We then looked for LAMP-1 staining by fluorescence microscopy. We 
were surprised to find that uninfected, resting macrophages expressed LAMP-1 on their 
surface (Fig 4.1A), which was inconsistent with published reports using other cell types 
such as fibroblasts, myoblasts and epithelial cells [1]. Others have also observed plasma 
membrane staining of LAMP-1 in resting macrophages (B. Byrne, M. Swanson lab, 
personal communication). There was no obvious visual increase in surface staining 
upon infection (Fig 4.1A). Thus, we concluded that infection with L. monocytogenes does 
not result in a detectable increase in LAMP-1 staining on the surface to BMDMs.  
     However, we reasoned that it if lysosomes were being recruited to a damaged 
plasma membrane, LAMP-1 might be degraded after fusion at the plasma membrane, 
which may result in the depletion of LAMP-1 from the intracellular compartment over 
time. Therefore, we performed the same infection protocol and permeabilized the cells 
with triton-X100 before staining with the anti-LAMP-1 antibody. We calculated the 
average intensity of LAMP-1 signal from fluorescence micrographs using Metamorph 
software and compared these values between infected and uninfected BMDMs. We  
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Figure 4.1 
 
Figure 4.1. LAMP-1 staining of BMDMs in response to infection. (A) BMDMs were 
incubated with 1:50 anti-LAMP-1 antibody (1D4B, cat #sc-19992, Santa Cruz) with or 
without triton treatment or L. monocytogenes. (B) Quantification of cells permeabilized 
with triton and then stained with anti-LAMP-1 antibody 8 h post infection. BMDMs 
were pretreated for 1 h with 100μM z-VAD-fmk (Enzo) and z-VAD remained constant 
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measured the opposite of what was predicted. Infection for 8 h increased the overall 
intensity of LAMP-1 staining (Fig 4.1C). This suggests that infection upregulates LAMP-
1 expression, and by proxy, lysosomes.  To determine whether caspases play a role in 
LAMP-1 expression or distribution during infection, we pretreated cells with 100μM z-
VAD-fmk, a pan-caspase inhibitor, for 1 h before infection. This concentration of z-VAD 
was maintained in the cell medium for the duration of the experiment. We discovered 
that z-VAD-treated, resting cells displayed an increase in LAMP-1 intensity compared 
to caspase-sufficient cells, but no difference was observed between infected and 
uninfected z-VAD treated cell populations (Fig 4.1C). From these methods, we 
concluded that LAMP-1 staining increases upon infection with L. monocytogenes, but not 
at the cell surface, and chemical inhibition of caspases does not alter the amount of 
LAMP-1 present in infected BMDMs.  
     Another way to test for the importance of lysosomal exocytosis during the caspase-7 
protective response to LLO damage is to assess whether a lysosomal enzyme, acid 
sphingomyelinase (ASM), contributes to repair. The Andrews lab determined that, 
during wound-induced lysosomal exocytosis, plasma membrane-fused lysosomes 
release enzymes into the extracellular space, including ASM, which converts 
sphingomyelin to ceramide. Ceramide-rich microdomains generated during lysosomal 
exocytosis are critical for the invagination of damaged sections of membrane [2]. 
Importantly, during TNFα receptor ligation, caspase-7 activates ASM [7]. Therefore, we 
hypothesized that the membrane integrity defect detected in csp7-/- cells might be due to 
a deficiency in the processing of ASM. We predicted if ASM deficiency is the source of 
the increased csp7-/- permeability, we should restore membrane integrity and measure 
less phalloidin influx during infection with the addition of exogenous ASM. Exogenous 
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addition of the enzyme was successfully used by Fernandes et al to restore T. cruzi 
invasion after ASM transcriptional silencing [8]. To test this hypothesis, we infected 
BL/6 and csp7-/- cells with L. monocytogenes. At 7 h pi, we added sphingomyelinase from 
Bacillus cereus to the cell medium. At 8 h pi we stained for phalloidin and assessed 
phalloidin influx using fluorescence microscopy. We tried several different infection 
conditions and concentrations of ASM, however we never saw consistent changes in 
phalloidin influx after ASM addition (Fig. 4.2A and B). Therefore, we conclude that 
ASM does not contribute to caspase-7-mediated membrane integrity. Combining results 
from figures 4.1 and 4.2, we conclude that lysosomal exocytosis does not contribute to 
caspase-7-mediated cytoprotectivity.   
 
Cholesterol biosynthesis during L. monocytogenes infection 
     Caspase-7 may regulate cholesterol biosynthesis. Caspase-7 was first identified as a 
protease capable of cleaving sterol regulatory element binding proteins (SREBPs) [9]. 
SREBPs are transcription factors bound to the ER membrane and nuclear envelope. 
When cells are depleted of cholesterol, proteolytic cleavage releases the bound 
transcription factor, which enters the nucleus to activate proteins involved in 
cholesterol biosynthesis and lipoprotein uptake [10]. Additionally, the Van der Goot lab  
demonstrated that caspase-1 activated SREBPs after PFT damage to promote survival of 
the intoxicated cell [6]. Although we had previously ruled out the contribution of 
caspase-1 in the caspase-7 protective phenotype in response to LLO damage (Chapter 
2), we reasoned it was possible that multiple caspases could regulate similar pathways. 
Thus, we hypothesized the csp7-/- cells display increased permeability after LLO-
mediated damage due to an inability to activate SREBPs, which would otherwise  
 
	   111	  
Figure 4.2 
 
Figure 4.2. ASM treatment of L. monocytogenes infected BMDMs. (A and B) BMDMs 
were infected at an MOI1 with L. monocytogenes for 7 h, after which 20mU/ml 
sphingomyelinase derived from Bacillus cereus (Sigma) was added to the cell medium. 
Cells were then incubated with 1:50 rho-phalloidin for 15 min and the percentage of 
phalloidin positive cells was determined from fluorescent micrographs. N > 200 cells 
per condition. A and B were performed 6 d apart, with cells derived from the same 
mouse, and treated with the same stock of sphingomyelinase. ** P < 0.001 by Student’s 
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 upregulate cholesterol biosynthesis and maintain membrane homeostasis after PFT 
injury. 
     To test this hypothesis, we first needed to determine if SREBPs were activated during 
infection with L. monocytogenes. We assayed for SREBP2 cleavage in BL/6 cells by 
immunoblot using different infection conditions. As a control, we incubated cells in 
DMEM without FBS for 1 h, and then added methyl-β-cyclodextrin for 30 min to 
deplete cellular cholesterol. We discovered that SREBP2 is not cleaved during any of the 
infection conditions tested (Fig 4.3A). Antibodies for other SREBPs were less reliable, so 
we shifted our focus to test whether we could measure transcription upregulation of 
cholesterol biosynthetic genes by qRT-PCR during infection. For these experiments we 
measured the transcription of two genes necessary for cholesterol biosynthesis, fatty 
acid synthase (FAS) and HMG-CoA-reductase (HMGCR), during infection at MOI5 and 
harvested samples for RNA extraction at various times post infection. We used the 
starvation condition for SREBP2 activation as a positive control. Using the cholesterol 
starvation condition that activated SREBP2, we measured a slight decrease in FAS 
transcript and no change in HMGCR (Fig 4.3B). It is possible that under our 
experimental control condition, we did not incubate long enough (1.5 h) to measure an 
increase in transcription of these genes by activated SREBP2. The cholesterol depletion 
protocol used induced morphological changes in the BMDMs, and we were careful to 
harvest the cells before we monitored significant cell death. However, it is striking that 
we measure a substantial decrease in the transcription of both FAS and HMGCR during 
the course of the infection, a result we replicated twice in independent experiments (Fig 
4.3B). This result cannot be explained by cell loss due to infection over time, as all 
samples were normalized to the level of actin transcript at each time point. Therefore, L.  
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Figure 4.3 
 
Figure 4.3. Cholesterol biosynthesis regulation during L. monocytogenes infection. 
(A) Samples from mock treated, cholesterol depleted and L. monocytogenes infected cell 
lysates were probed for the cleavage of SREBP2 by immunoblot. The predicted cleavage 
product migrates at 68 kDa; the source of the 90 kDa fragment is unknown, but was 
consistently present in cholesterol depleted samples in 3 separate experiments. (B) Fold 
change by qRT-PCR in transcript levels of either fatty acid synthase or HMG-CoA-
reductase compared to actin transcripts during cholesterol depletion or infection with L. 
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monocytogenes infection induces a decrease in cholesterol biosynthetic transcript levels. 
     A possible explanation for this result is that the interferon response to L. 
monocytogenes infection is responsible for the decrease in cholesterol biosynthetic 
transcripts. L. monocytogenes has been long known to stimulate IFN production [11], and 
interferons are key regulators of lipid metabolism [12]. Additionally, interferon-induced 
lipid metabolic alterations have been described during L. monocytogenes infection [13]. 
Therefore, it is possible that the transcriptional program activated by interferon 
signaling supercedes any potential cholesterol requirements at the membrane due to 
PFT damage. It is also possible that, instead of activating cholesterol biosynthesis to 
heal damaged membrane, the host cell co-opts internal stores of membrane and 
repurposes those to patch holes. We did not observe the lysosomal compartment being 
used in this manner (Fig 4.1 and 4.2), however, there are many other sources of 
membrane in the intracellular compartment, perhaps the most abundant of which is the 
ER. 
 
ER stress and membrane integrity during L. monocytogenes infection 
     The ER is an interconnected network of membrane vesicles that act as the site of 
protein folding and posttranslational modification within the cell. Perturbations in 
proper protein synthesis can induce ER stress. Also known as the unfolded protein 
response (UPR), this signal transduction pathway increases the biosynthetic capacity 
and decreases the biosynthetic burden of the ER to maintain homeostasis. Infection with 
a variety of pathogens can also stimulate the UPR and inform the innate immune 
response [14]. Activation of the UPR stimulates increased vesicular traffic between the 
ER and Golgi [15]. Importantly, infection with L. monocytogenes activates the UPR in an 
LLO-dependent manner [16]. Since caspase-7 can interact with ER membrane proteins 
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[9], we hypothesized that ER stress activation in response to Listeria infection or LLO 
may increase ER-derived vesicular traffic to the PFT damaged plasma membrane, and 
that this process may be perturbed in csp7-/- cells.   
     Since there are many arms to the UPR, and many pathogens and perturbations 
selectively activate some arms but not others, one of the first experiments we performed 
was a visual analysis of ER stress in response to LLO treatment. We hypothesized that 
treatment with an ER stress-inducing agent may stimulate morphological changes in 
the ER compartment, similar to morphological changes during mitochondrial stress 
[17], which could be monitored using fluorescence microscopy and an antibody to an 
ER luminal protein, protein disulfide isomerase (PDI). We treated RAW cells with 0.5 
μg/ml LLO for 1 h and then stained for PDI. We used tunicamycin treatment, which 
activates all three arms of the UPR, as a positive control.  We saw small differences 
between untreated, tunicamycin treated, and infected cells; the most obvious was 
increased punctate staining in the tunicamycin treated group (fig 4.4A). However, 
because these differences were difficult to quantify, we instead focused on molecular 
techniques to determine if LLO treatment caused UPR activation.  
     Work in the Ragahavan lab demonstrated that, during thapsigargin-induced UPR 
activation, dendritic cells secrete some ER resident proteins, one of which is PDI [18]. 
Therefore we wanted to determine whether PDI was secreted from BMDMs during 
intoxication with LLO. We treated cells with 0.25 or 0.5μg/ml LLO for 3 or 6 h, and then 
harvested supernatants to probe for PDI secretion by immunoblot. We used 
supernatants from thapsigargin treated cells as a positive control. We were able to 
visualize the secretion of PDI once (Fig 4.4B) but never again (Fig 4.4C). It is possible 
that we were at the limit of detection for the antibody, and immunoprecipitation or  
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Figure 4.4 
 
Figure 4.4. Monitoring PDI as a marker of ER stress in response to PFT damage. (A) 
RAW cells were stained using an anti-PDI antibody (Cell Signaling cat #3501) to 
monitor visual changes in the ER in response to chemical induction (tunicamycin 
treatment – TN) and LLO treatment. (B and C) Secretion of PDI into the cell supernatant 
after chemical induction (thapsigargin – THP) or LLO treatment as assessed by 
immunoblot using the same antibody as in (A). LLO concentrations are in μg/ml. Cells 
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trichloroacetic acid precipitation of protein would improve the regularity of PDI signal 
on my immunoblots, especially considering we inconsistently saw PDI secretion in the 
positive control lysates.  However, there are many ways to detect ER stress, so we 
decided to try another technique.  
     There are three ER stress sensors that, upon activation, drive the physiological 
response to the UPR. These sensors, IRE1α, PERK, and ATF6, can be preferentially 
activated to induce cellular processes not related to protein folding, such as innate 
immunity and metabolism [19]. Infection with intracellular pathogens can activate 
some, but not necessarily all, of the UPR sensors [16,20,21]. Therefore, we tested 
whether any of the UPR sensors were activated during infection with L. monocytogenes 
or after treatment with LLO.  
     IRE1α is an ER-anchored kinase and ribonuclease that functions to post-
transcriptionally modify xbp1 RNA. Xbp1 is a transcription factor whose activity is 
greatly increased by IRE1α splicing [14]. There is a strong connection in the literature 
between IRE1α and intracellular infection [21]. Therefore, we first tested whether 
chemical inhibition of this sensor would result in increased permeability during 
infection with L. monocytogenes. We hypothesized that if IRE1α signaling was needed to 
increase vesicular traffic to injured membrane during infection, then chemical inhibition 
of IRE1α would increase permeability over time, similar to the permeability phenotype 
seen in the csp7-/- BMDMs (Fig 2.4). To test this, we pre-treated RAW cells for 1 h with 
the IRE1α inhibitor, irestatin, and then infected at MOI5. After a 30 min incubation, cell 
medium was removed and 50μg/ml gentamicin was added to kill any extracellular 
bacteria. In control groups, gentamicin was removed 2 h pi and replaced with media 
containing no antibiotic. Cells were lysed at various time points post infection and 
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assessed for intracellular CFU. We found the irestatin treatment did have an effect on 
the intracellular growth of L. monocytogenes (Fig 4.5A). However, this inhibitor affected 
the entry and escape of L. monocytogenes, as fewer bacteria were inside host cells after 1 
h. This defect was overcome over time as the slope of intracellular growth sharply 
increased between 4h and 8 h pi  (Fig 4.5A). Because the presence of gentamicin in the 
extracellular space did not inhibit the growth of L. monocytogenes inside irestatin treated 
cells over time, unlike csp7-/- cells (Fig 2.4), this indicates irestatin treatment does not 
result in increased permeability during infection. Therefore, we concluded that IRE1α is 
important during L. monocytogenes infection, but does not correlate with increased 
permeability to small molecules as a result of increased PFT damage. 
     Pillich et al reported that extracellular L. monocytogenes were capable of activating 
IRE1α using xbp1 splicing as a read out, and attributed that activation to LLO secretion 
[16]. We hypothesized that pleiotropic effects of IRE1α inhibition during L. 
monocytogenes infection could be masking the importance of this sensor in response to 
PFT damage. Therefore, we assayed the ability of exogenous LLO treatment to 
stimulate xbp1 splicing in BMDMs. The unspliced xbp1 mRNA contains a Pst1 digestion 
site, however IRE1α splicing removes this sequence. Therefore Pst1 treatment of DNA 
made from xbp1 RNA can be used to differentiate spliced from unspliced transcript. We 
treated cells with a range of concentrations of LLO and harvested for RNA at 1, 3 and 6 
h post-intoxication. We used thapsigargin treatment as a positive control. We saw no 
xbp1 splicing in any experimental condition tested, even at lytic concentrations (0.75 and 
1.0 μg/ml) of toxin (Fig 4.5B). Xbp1 splicing is regarded as the most sensitive method of 
detection for IRE1α activation.  Therefore, we conclude that PFT damage by LLO does  
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Figure 4.5 
 
Figure 4.5. Activation of the UPR in response to LLO damage. (A) RAW cells pre-
incubated with 25μg/ml irestatin for 1 h; this concentration wa maintained throughout 
the experiment. Cells were infected at MOI5 for 30 min, after which the inoculum was 
removed and media containing 50μg/ml gentamycin. For WO conditions, gentamycin 
was removed from the media 2 h pi. RAW cells were lysed and CFU were enumerated 
using serial dilution of lysates onto agar plates. (B) xbp1 splicing was assessed under 
various LLO treatment conditions (concentrations of LLO are μg/ml), using Pst1 
digestion. Spliced transcripts are resistant to Pst1 digestion and therefore migrate 
higher than unspliced transcripts. (C) immunoblot for PERK protein (Cell Signaling, cat 
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not stimulate this arm of the UPR.      
     ATF6 is another sensor of ER stress that resides in the ER membrane. Activation 
induces ATF6 to translocate to the Golgi where it is proteolytically processed to an 
isoform capable of activating the transcription of a variety of degradative proteins [19]. 
Therefore, the activation of ATF6 can be monitored by immunoblot using an antibody 
that can detect the cleaved fragment. We probed for the activation of ATF6 and a 
downstream effector, CHOP, in BMDMs intoxicated with LLO but were unable to 
detect cleavage of either protein (data not shown). Others in our laboratory have 
success using these antibodies (personal communication). Therefore, we conclude that 
ATF6 is not likely to be activated by LLO treatment.  
     A third ER stress sensor is PERK, a kinase that undergoes oligomerization and 
autophosphorylation upon activation. This leads to the translational activation of the 
transcription factor ATF4 and causes attenuation of global mRNA translation by 
phosphorylating the α-subunit of the regulating initiator of the translation machinery, 
eIF2 [14]. The most common ways to assay for PERK activation are using immunoblot 
and probing for either the phosphorylation of PERK or eIF2. When we assayed for 
PERK phosphorylation we saw a curious result. Tunicamycin (TN) treatment resulted 
in a slight size shift compared to mock treated cells, consistent with slower migration 
resulting from the phosphorylation modification (Fig 4.5C).  However, treatment with 
0.25 μg/ml LLO for 1, 2, or 4 h produced a banding pattern on the immunoblot not seen 
in mock or tunicamycin treatment (Fig 4.5C). This result suggested that PERK might be 
degraded in response to LLO treatment. We were able to replicate this result using the 
same lot of antibody, however, when we purchased more of the same antibody (but 
from a different lot) and different antibodies from other companies, we never again saw 
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the banding pattern, nor did we ever see the phosphorylation size shift seen in the 
positive control sample. A possible interpretation of the banding pattern is that proteins 
were degraded during the lysate harvest. However, all samples were treated 
equivalently using the same lysis buffer with protease inhibitors, and therefore, it is 
unlikely that some samples would experience degradation and not others. We were 
unable to find any evidence in the literature of PERK degradation, which suggests that 
PERK degradation in response to LLO-treatment may be a novel phenomenon. We 
were unable to detect eIF2 phosphorylation in response to LLO treatment. Therefore, 
we hypothesis that the ER stress sensor PERK may be proteolytically degraded in 
response to LLO treatment, but different tools need to be used to assess this more 
directly.    
     Although the results of the ER stress experiments are inconsistent, it is likely that 
LLO damage does not classically activate any of the three known UPR sensors in 
BMDMs. This conclusion conflicts with results published by Pillich et al, which suggest 
that exogenous LLO damage stimulates the UPR [16]. It is possible that differences in 
cellular responses between cell types account for this conflict; they used P388D1 cells, 
which are a human macrophage cell line, and we use RAW cells and BMDMs, both of 
murine origin. This does not rule out ER contribution, in some way, to the response to 
PFT damage. Work in the Weiss lab demonstrated in mast cells that the ER rapidly 
releases Ca2+ in response to LLO-mediated damage [22]. Additionally, our laboratory 
has data suggesting that chemical induction of ER stress activates caspase-7 (data not 
shown).  More studies need to be done to determine whether the ER contributes to PFT-
damaged membrane repair, and whether this accounts for the defect seen in csp7-/- 
BMDMs.  
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Autophagy and membrane repair after PFT treatment 
     Autophagy is a process by which cells can balance catabolic requirements during 
times of stress, remove misfolded or aggregated proteins, and clear damaged 
organelles. Autophagy can also aid the clearance of intracellular pathogens, such as 
Shigella and Legionella [23,24]. Infection with L. monocytogenes stimulates autophagy as a 
result of LLO-mediated phagosomal lysis; however, the role of autophagy in promoting 
the clearance of L. monocytogenes is controversial [25,26]. Liposomes loaded with 
purified LLO are sufficient to stimulate autophagy, indicating that internal membrane 
damage, independent of infection, is a trigger for this response [25].  It is possible that 
exogenous treatment with LLO could also activate autophagy.  Thus, autophagosomes 
represent a possible source of membrane that could be co-opted to patch plasma 
membrane after LLO-mediated damage.       
     To determine whether exogenous LLO treatment stimulates autophagy, we 
performed live cell imaging on macrophages isolated from mice expressing GFP-labeled 
LC3, which is a marker for autophagosomes (a gift from M. Swanson) [27]. We used the 
same protocol for live cell imaging outline in Chapter 3. We measured no LC3-positive 
punctae in resting cells, however intoxication with LLO resulted in punctae formation 
in 60% of cells monitored (Fig 4.6), with an average of 3 punctae per cell. From this 
result, we conclude that autophagy is activated by exogenous treatment with LLO. 
     Using this method of investigation however, it was not clear whether autophagic 
vesicles were being recruited to the cell surface, which would indicate that autophagy 
may contribute to membrane healing after PFT damage. Using fixed-cell microscopy, 
the M. Swanson lab measured no increase in LC3 positivity on the plasma membrane of 
LLO-treated cells compared to un-intoxicated controls (personal communication). 
However, they did measure an increase in intracellular LC3-punctae similar to what we 
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Figure 4.6 
 
Figure 4.6 Autophagy is activated by exogenous LLO treatment and is reduced by 
myosin II inhibition.  Macrophages isolated from mice expressing GFP-tagged LC3 
were plated for live cell imaging at a concentration of 1.5 x 105/plate. Just before 
imaging, LCI media was added to the cells (see Chapt. 3 for details). Micrographs in 
phase and the FITC filter were captured before the addition of LLO. LLO was added to 
the plates at a final working concentration of 0.1μg/ml. For blebbistatin treatment, cells 
were incubated for 30 min in 50μg/ml blebbistatin before the addition of LCI media + 
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observed using live cell imaging. Although these experiments require more replicates, 
the preliminary data suggest that while autophagy is activated by LLO-treatment, LC3 
positive vesicles are not being recruited to the cell surface to patch damaged membrane.   
     Interestingly, treatment of cells with the myosin II inhibitor, blebbistatin, resulted in 
a decrease in LC3-positive cells in live cell imaging (Fig 4.6), which suggests that 
myosin motor proteins may play a role in autophagy. These results are preliminary and 
need to be repeated to determine if a role exists for myosin in the generation of 
autophagosomes, and whether autophagic membrane is recruited to the cell surface 
after PFT damage.   
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3. Discussion 
     These experiments contain some hints that internal membrane that could be used to 
patch plasma membrane lesions caused PFT damage. However, more thorough 
research needs to be done to determine whether membrane is repurposed to ameliorate 
plasma membrane damage. Additionally, some sources of internal membrane were not 
researched. For instance, membrane originating for the Golgi was shown to be 
important in healing cells infected with Mycobacterium tuberculosis [3]. Also, it has been 
reported that the architecture of the mitochondrial network undergoes rapid, transient 
changes after treatment with LLO [17], and perhaps mitochondrial membrane could 
plug plasma membrane damage after pore-formation. More experiments need to be 
performed before ruling out a role for internal membrane in the resolution of PFT 
damage at the plasma membrane. 
     A confounding issue of detection might be the rapid turnover of markers used to 
label different intracellular compartments. This is not reported to be the case for the 
lysosomal marker LAMP-1 [1], however, turnover kinetics may differ between 
intracellular compartments and in different cell types. One method of investigation that 
could alleviate the issue of marker turnover would be to label intracellular 
compartments directly, and monitor their behavior after the addition of LLO using live 
cell imaging. We used this method to label Golgi with Bodipy-C5-ceramide, which 
preferentially accumulates in this organelle [28].  We did not notice obvious changes in 
staining after treatment with LLO (data not shown), however it is possible that another 
intracellular compartment may provide membrane to the site of PFT injury that we 
have yet to label in this manner. We hypothesize repurposed internal stores of 
membrane for plasma membrane repair after PFT damage remains a viable hypothesis 
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supported by the literature [1,3], and improved techniques may illuminate which 
compartments contribute to repair.    
      It is also possible that new membrane is made de novo in response to PFT damage. 
qRT-PCR of cholesterol biosynthetic genes during L. monocytogenes infection did not 
support this hypothesis, however, pleiotropic effects of interferon signaling during 
infection may have confounded  analysis. Additionally, other genes may be responsible 
for lipid biogenesis in this context. We believe there is still value in looking at whether 
lipid synthesis is upregulated in response to LLO treatment, but using exogenous toxin 
instead of infection would be ideal for experimentation moving forward. We and others 
have shown that LLO treated cells undergo transient metabolic quiescence after LLO 
treatment (Chapter 3 and [17]), and this data should inform the likely timing of when 
transcriptional activity can be measured. It is also possible that lipid synthesis could be 
stimulated without gene transcription, for instance by the stimulation of lipid catabolic 
pathways repressed under resting conditions.  Therefore, a more thorough analysis of 
lipid synthesis may illuminate whether membrane is made in response to LLO-
mediated damage.  
     It is also possible that membrane is repaired without the aid of alternative membrane 
sources or de novo synthesis. This could be the case if PFTs were, for instance, 
proteolytically degraded at the plasma membrane. The resulting PFT fragments could 
be taken up into autophagic compartments for further processing. Then, as the PFT is 
degraded, membrane lesions would resolve due to hydrophobic bilayer re-fusion. 
Utilizing the concepts presented in Chapter 3, this would suggest that proteolytic 
proteins must be present inside membrane blebs after PFT damage. In order to get to 
the site of damage, it is possible that the proteolytic degradation machinery is 
endogenously present at the bilayer, perhaps through interaction with the cortical 
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cytoskeleton, or that it is rapidly recruited to damage sites, for instance via the sensing 
of ion flux. To test this, we could isolate resting membrane and toxin-induced blebs by 
ultracentrifugation and/or sucrose gradation and then assay for what is present inside 
the blebs or at the membrane. Current efforts in the lab are focused on isolation of blebs 
from intoxicated cells.  
     The experiments carried out through the course of this dissertation have identified 
molecular players involved in membrane maintenance after LLO intoxication. 
However, more work is needed to identify the physical mechanism by which the 
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Caspase-7 is the middle of the story 
     Unknown are the signals and/or upstream factors that stimulate caspase-7 after PFT 
treatment. To our knowledge there are no instances in the literature where caspase-7 
undergoes autocatalysis. The best studied pathways that activate caspase-7 are the 
intrinsic and extrinsic mechanisms of apoptosis, both of which rely on initiator caspases 
-8/-10 or -9 for caspase-7 cleavage [1]. Our laboratory has preliminary data suggesting 
caspase-9 is activated by LLO treatment with similar kinetics to caspase-7 (data not 
shown), which would suggest the involvement of mitochondria in the toxin response. 
The Cossart group published data suggesting that the mitochondrial network 
undergoes dramatic but transient rearrangement after treatment with LLO [2]. Whether 
caspase-9 is activating caspase-7 after PFT damage has not yet been determined, but it is 
interesting to speculate that transient mitochondrial dysregulation stimulates 
components of the intrinsic apoptotic pathway to promote membrane repair after 
treatment with LLO.   
     As previously mentioned in Chapter 4, ER stress has been associated with caspase-7 
activation, namely through proteolysis by caspase-12, although this connection is 
controversial [3-5].  We were unable to detect ER stress in response to LLO, therefore, 
caspase-12 is not the most likely candidate for PFT induced caspase-7 activation, but 
this has yet to be tested. However, Ca2+ sensing represents a viable mechanism by 
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which caspase-7 directed repair may be initiated, and it is possible that a non-caspase 
protease is responsible for caspase-7 cleavage. In chapter 4, we discussed the 
importance of Ca2+ signaling in repair and blebbing and others have shown that 
calpain-1, a Ca2+-dependent cysteine protease, can activate caspase-7 [6]. We have yet to 
determine if calpain-1 cleaves caspase-7 during intoxication. But, given the known role 
for Ca2+ during intoxication and repair [7-9], we speculate that Ca2+-dependent signaling 
is critical for the execution of the caspase-7 cytoprotective response.    
      Also unknown is how cleaved caspase-7 is turned over in response to PFT 
treatment. Transient activation of caspase-3 has been implied for the differentiation of a 
variety of cell types [10,11], but resolution of caspase-3 cleavage has only been 
demonstrated in the transition from myoblasts to skeletal muscle cells [12].  The 
mechanism by which active caspases are turned over during cell differentiation was not 
addressed in these papers, however there are some hints in the literature about how this 
might be achieved. Inhibitor of apoptosis proteins (IAPs), as their name suggests, are a 
large family of proteins that function to suppress programmed cell death in host cells 
[13].  Of particular interest are the c-IAPs, which contain a caspase recruitment domain 
(CARD) in additional to the standard baculovirus IAP repeat (BIR) and RING domain 
typified by this family. Work by Choi et al has demonstrated that cIAP1 binds to the 
active form of caspase-7 [14]. The RING domain of cIAP1 ubiquitinated the larger active 
subunit of caspase-7 to promote its degradation by the proteasome [14]. Therefore, we 
hypothesize that toxin-induced, activated caspase-7 may be turned over in the same 
manner. Whether active caspase-7 is bound by c-IAP1 and/or ubiquitinated after PFT-
induced activation is currently being investigated.  
 
Mechanisms of caspase activation and implications for partial activation 
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    Caspases are resident in the cytosol of cells as zymogens often called pro-caspases. In 
a resting state, proteolytic activity is constrained by the structural conformation of these 
proteins.  For the initiator caspases, pro-caspase monomers are recruited to polymeric 
activation platforms, and the subsequent dimerization of pro-caspases induces an 
activating rearrangement called the induced proximity model of activation [15,16]. 
Auto-processing after dimerization of the initiator caspases -8 and -2 promotes stability 
and protease activity [16-18]. However, inter-domain cleavage after dimerization of the 
initiator caspase-9 attenuates its activity[16,19]. Thus the initiator caspases can be 
controlled by cleavage with divergent outcomes for their proteolytic capacity.   
     In contrast, the executioner pro-caspases -3 and -7 exist as dimers in the cytosol and 
generally require cleavage by an external protease to promote their activity [20-22]. 
Cleavage results in two antiparallel heterodimers, each composed of a p20 and p10 
subunit. Each exposed p20 subunit contains the catalytically active site, whereas the p10 
subunit forms the substrate-binding pocket [23,24]. Therefore, the intramolecular 
rearrangement resulting from activating cleavage helps define the active site of caspases 
-3 and -7. It is interesting to speculate that cleavage may represent a mechanism by 
which caspase activity can be finely tuned. In this case, the canonical cleavage site may 
form a substrate-binding pocket selective for apoptotic substrates. However, if caspase 
activity is needed to drive a survival response, alternative cleavage could form an active 
site specific for a defined subset of proteins whose cleavage supports an adaptive 
response.   
     The kinetics and mechanism of activation may explain how specificity of the caspase-
7 cytoprotectivity is achieved. Recent work elegantly described the structural changes 
that occur during the transition from pro-form to active form for both caspases -3 and -
7. The authors found that caspase-3 activation is “all or nothing”: The pro-form is 
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catalytically inactive and both heterodimers mature concurrently at maximal activity 
[25]. However, pro-caspase-7 maturation is significantly different. Pro-caspase-7 has 
latent, albeit weak, catalytic activity [25], which suggests that alterations in structure, in 
the absence of direct cleavage, are sufficient to expose the caspase-7 catalytic site (Fig 
5.1). It is possible that protein-protein interaction could provide the context for the 
caspase-7 cytoprotective response, whereby off-site binding could deform pro-caspase-7 
sufficiently to expose to the active site. This may also help to explain the relatively low 
cleavage of caspase-7 in response to PFT damage, despite that striking phenotype in 
csp7-/- cells. Thus, we may be overestimating the importance of cleavage to the activity of 
caspase-7.  Additionally, the uncleaved, but active, enzyme would have a different 
substrate-binding pocket than the cleaved form, and could have preference for 
substrates involved in the adaptive survival response as opposed to substrates 
responsible for the execution of apoptosis.   
     Caspase-7 can exist in a partial activation state, where one heterodimer is immature 
and one is cleaved [25,26] (Fig 5.1). Partial activation may help to temper the catalytic 
capacity of caspase-7. We have demonstrated the activation of proteins important in 
apoptosis, such as ROCKs, in a caspase-7 dependent in manner after intoxication, in the 
relative absence of cell death. It is possible that partial maturation of caspase-7 is 
insufficient to stimulate an apoptotic cascade within the cell. Indeed, research suggest 
that caspase-3 is the predominate caspase responsible for the execution of apoptosis 
[27]. Our data suggests that caspase-3 is very weakly activated by infection (Fig. A2), 
which may also explain why Listeria infected cells are not apoptotic.  
     During apoptosis, caspases -3 and -7 display overlapping substrate specificity. 
However, careful studies have identified proteolytic targets unique to each enzyme 
both in vitro and in vivo [27,28]. Additionally, proteomics and synthetic chemistry have 
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Figure 5.1 
 
Figure 5.1 Models of caspase-7 activation. Pro-caspase-7 exists in the cytosol as a dimer 
with an anti-parallel conformation. Unlike pro-caspase-3, pro-caspase-7 can have 
proteolytic activity in the absence of cleavage [25]. Caspase-7 can also exist in a partially 
mature state, where the linker region occluding one active site is cleaved [25,26]. 











   caspase-7
      Inactive
   pro-caspase-7
       Active
   pro-caspase-7
Fully mature
  caspase-7
	   136	  
identified peptides cleaved by one but not the other caspase [28], indicating these two 
enzymes are not functionally redundant. However, there is little evidence in the 
literature of selective activation of these two proteases. As such, the question arises as to 
how caspase-activating specificity is achieved during infection. It is possible that 
subcellular location shapes the resulting response. Caspase-7 is reported to associate 
with plasma membrane-proximal structures [29], and thus could be in close proximity 
to the signaling cascade resulting from PFT-derived membrane damage.  
 
A role for caspase-3 during intoxication? 
     In this body of work, we have demonstrated a role for caspase-7 in promoting 
membrane integrity after damage by the pore-forming toxin (PFT) listeriolysin O, LLO. 
Given that caspase-7 and caspase-3 are both activated during apoptosis and cleave 
many of the same substrates, the question arises as to whether caspase-3 may also play 
a role in membrane protection after PFT damage. In chapter 2, we demonstrated that 
caspase-3 is not activated as strongly as caspase-7 in the context of infection (Fig. A2) 
[30]. This result is recapitulated in the context of toxin treatment as well. At sub-lytic 
concentrations of LLO (0.25μg/ml), we can detect caspase-7 activation as early as 30 
min post toxin treatment in the absence of caspase-3 cleavage (Fig. 5.2). We also detect 
no caspase-3 cleavage after 1 h of toxin treatment, however, if we allow the cells to 
incubate with toxin for longer periods of time, caspase-3 does eventually become 
activated in BL/6 and csp7-/- cells (Fig 5.2). Recent reports suggest the threshold of 
activation of caspase-7 is lower than caspase-3 [25], which may represent a mechanism 
by which the cell diverts adaptive caspase signaling from apoptotic caspase signaling.  
Importantly, this experiment also demonstrates that there is no compensatory 
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upregulation of caspase-3 activity in the absence of caspase-7, unlike what has been 
observed under other experimental conditions [31,32] (Fig 5.2). In fact the opposite 
seems true; there is less caspase-3 activation in the csp7-/- cells compared to BL/6. It is 
unlikely that caspase-7 is activating caspase-3 as this does not occur in vitro [33]. 
Therefore, this suggests caspase-7 plays a non-redundant role in protecting the 
membrane after PFT damage. 
    I speculate that the appearance of caspase-3 activation after longer periods of 
intoxication may indeed be a bellwether of apoptosis. During initial PFT damage, 
caspase-7 is activated to stimulate the repair of damaged membrane, but in the absence 
of adequate repair, or during continuous and unresolved damage by LLO, programmed 
cell death is invoked by caspase-3. It is also possible that, during unresolved damage, 
caspase-3 is activated to aid the repair process.  Since inducers of apoptosis tend to 
activate both proteases equivalently, sequential activation could act as a hallmark to 
shunt the cell into repair and not death. If caspase-3 does promote repair, we 
hypothesize that the csp3-/- cells should behave similarly to the csp7-/- cells when 
damaged by PFTs. The role of caspase-3 activation during LLO treatment has yet to be 
tested. However, based on the delayed kinetics of caspase-3 activation in response to 
toxin treatment, we favor a model whereby caspase-7 is the principal caspase 
orchestrating membrane repair after PFT injury.  
     Although caspase-3 and -7 have considerable overlapping substrate specificity, there 
are reports highlighting the differences between these proteases. For instance, several 
reports indicate that caspase-3 is the more proteolytically active caspase on a variety of 
substrates [33-36]. Higher proteolytic activity of caspase-3 may represent another reason 
why the cell would preferentially activate caspase-7 over caspase-3 when repairing 
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Figure 5.2 
 
Figure 5.2. Caspase-3 is activated with slower kinetics than caspase-7 in response to 
toxin treatment. BMDMs were intoxicated with 0.25µg/ml LLO for the indicated times, 
after which the cells were lysed and probed for caspase-7 and caspase-3 cleavage (Cell 
Signaling cat #9492 and #9665 respectively) and actin. Treatment with TNFα and 
cyclohexamide (TNFα+ CHX) was used as positive control for cleavage of both 
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damage rather than inducing apoptosis. Others have reported that caspase-3 directly 
cleaves ROCK I during programmed cell death to promote membrane blebbing [37,38]. 
We currently have no evidence that caspase-7 cleaves ROCK I directly during PFT 
damage, but it is possible, given the large number of shared targets between these two 
proteases that ROCK I is cleaved by caspase-7 to orchestrate blebbing after LLO 
treatment. It is also possible that caspase-7 does not directly cleave ROCK I, but 
promotes the activity of the kinase in other ways discussed below. In this example, the 
lower proteolytic activity of caspase-7 may be beneficial to the cell. ROCK I can be 
activated by several mechanisms including cleavage, phosphorylation, and 
dimerization [39-41]. Cleavage is an irreversible activation which increases the activity 
of this protein 8-fold [38], and we have yet to find in the literature a mechanism by 
which cleaved ROCK I is turned over. Therefore, cleavage of a large proportion of 
ROCK I may not represent the most efficient mechanism to achieve transient or acute 
activation. The lower proteolytic activity of caspase-7 may help to regulate the amount 
of ROCK I activated, which could in turn regulate unmitigated signaling resulting in 
apoptosis. Additionally, caspase-7 activity may indirectly activate the rho-kinases, 
through promoting their phosphorylation for example. ROCK I activated in this manner 
could then be deactivated by a phosphatase when membrane damage is resolved. Thus, 
the specificity of the blebbing response to toxin, employing proteins with known roles 
in apoptosis, may be conferred and controlled by the strength of signal received.  
 
Live to fight another day    
     For macrophages, there are many potential benefits to withstanding damage by 
PFTs. Macrophages are amoung the first responders to an infection, and as such 
encounter a variety of membrane-damaging agents. Their ability to aid in the clearance 
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of infection likely depends on their ability to survive such insults. Similarly, 
macrophages that survive such damage promote inflammation by cytokine secretion 
and adaptive immunity through antigen presentation. Thus, having mechanisms in 
place to protect macrophages from infectious membrane damage is beneficial to many 
arms of the immune system. However, the ability of macrophages to heal from PFT 
damage may also be a consequence of their lifestyle. As mentioned previously, some 
cell types use blebbing as a form of motility [42], and because macrophages are motile 
cells, they likely encounter membrane stress traveling to different locations in the host. 
Therefore, it is also possible that macrophages have adapted to repair acute membrane 
damage independent of infection, but this ability fortuitously improves immunity by 
extending the life span of macrophages under attack.    
     However, in the case of intracellular pathogens such as L. monocytogenes, extending 
the life of macrophages greatly benefits the invader as well. This is exemplified by 
infection with L. monocytogenes that produces a hyperactive allele of LLO, or a copy of 
LLO deficient in translational repression. These bacteria are attenuated in mouse 
models of infection, presumably because misregulated LLO overtakes the cells ability to 
repair PFT damage resulting in cell lysis and exposing L. monocytogenes to neutrophils, 
against which they have little defense [43-45]. Thus, the bacterium must tune the 
production of LLO in the macrophage to a balance that promotes both its escape from 
the cytosol and the resolution of collateral damage at the plasma membrane. 
 
The importance of this work 
     The contribution of this dissertation research to the advancement of science lies in 
two broad concepts: duality and signal strength. Caspase-7, Rho-kinases, and myosin II, 
proteins with defined roles in the execution of apoptosis, are also needed to stimulate 
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membrane repair and survival in the context of LLO-mediated membrane damage.  As 
previously discussed, I speculate the low-level activation of caspase-7 is the key to 
defining the downstream response, in this case, the difference between survival and 
programmed cell death. Figure 5.3 illustrates this idea as a graphic. This idea is not new 
to science, but I feel the work outlined in this dissertation provide strong evidence for 
the importance of this concept. When I first presented this research, it was suggested 
that the DEVDase activity (a marker of caspase3/7 activity) in infected cells was very 
weak compared to staurosporine (an inducer of apoptosis) treatment, and that the small 
increase in activity over baseline was not significant. I was fortunate to have genetic 
data supporting a role of caspase-7 during infection, but I use this anecdote as an 
example of our internal bias as scientists that more is better.  
     I propose that a large part of the dichotomous role of caspase-7 lies not only in the 
amount of caspase-7 activated, but also its rapid turn over once membrane integrity has 
been reestablished. In RAW cells we detect decreases in cleaved caspase-7 as early as 2 
h after toxin removal, which correlates well with decreased permeability to small 
fluorescent molecules (Fig 3.1). Thus, caspase-7 is degraded when the signaling it 
generates is no longer needed, reducing the likelihood of unintended apoptotic 
activation. The concept of signal strength is gaining support in the literature thanks in 
part to more sensitive detection methods that have uncovered low-level, but 
physiologically relevant, changes after cell stimulation. Understanding the underlying 
signals that promote cellular homeostasis and survival are integral to our 
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Figure 5.3   
 
Figure 5.3.  A schematic of the dichotomous roles of activated caspase-7. When a small 
proportion of caspase-7 is activated by LLO-mediated membrane damage, the resulting 
response favors membrane integrity and cell survival. When a larger proportion of total 
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Appendix I 
Purpose 
     The following section contains figures supplemental to the main chapter discussions. 
Figures A1-A7 were included as supplemental material to the PLoS Pathogens paper, 
and are referenced in Chapter 2. Figure A8 is an immunoblot demonstrating transient 
activation of caspase-7 in response to LLO treatment in BMDMs. This data is referenced 
in Chapter 3. Figure A9 demonstrates that loss of caspase-7 renders BMDMs more 
permeable to small molecules after treatment with LLO. This is referenced in Chapter 3 
and supported by data included in Figure 3.1. 
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Figure A1. 
 
Figure A1. Infection at MOI1 and MOI5 results in equivalent intracellular CFU by 8 h 
pi. BL/6 BMDMs were infected at the indicated MOI for 30 min, after which 10µg/ml 
gentamicin was added to the cell culture medium to inhibit extracellular bacterial 
replication. Intracellular CFU were enumerated 8 h pi by osmotic lysis and serial 
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Figure A2. 
 
Figure A2. Caspase-3 is weakly cleaved in response to L. monocytogenes infection. 
BL/6 BMDM were infected with L. monocytogenes and cell lysates were probed with an 
antibody that recognizes full-length and cleaved caspase-3 (Cell Signaling Technology). 
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Figure A3. 
 
Figure A3. Most L. monocytogenes infected cells do not display common markers of 
apoptosis. BL/6 BMDMs were infected at MOI5 with L. monocytogenes for 6 h and then 
stained for phosphotidyl serine exposure using Annexin V according to the 
manufacturer’s instructions (Biotium, Inc. Hayward, CA). The percentage of cells 
positive for Annexin V was determined via fluorescence microscopy of duplicate 
samples N > 100 cells per condition. Cells were treated with 1μM staurosporine for 4 h 
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Figure A4. 
 
Figure A4. Caspase-7 deficient cells retain LDH at similar levels as BL/6 cells during 
infection. BMDMs isolated from BL/6 and caspase-7-deficient mice were infected at 
MOI5 with L. monocytogenes for 8 hafter which release of lactate dehydrogenase (LDH) 
into cell culture supernatants was determined. The amount of LDH released as the 
result of detergent induced lysis was set to 100% and the amount of signal from 
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Figure A5. 
 
Figure A5. WT and iLLO strains grow to equivalent intracellular CFU by 8 h pi.  
WT BMDMs were infected using the indicated strains and conditions for 8 has in Fig. 
A1. Intracellular CFU were enumerated by osmotic lysis of macrophages and serial 
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Figure A6. 
 
Figure A6. BMDM treated with low concentrations of exogenous LLO do not release 
LDH by 5 h pi. BMDM cultures from Fig 2.6C were washed 1 h post toxin treatment, 
after the initial LDH release measurement, and fresh medium was added to the cells. 
LDH released into the medium was measured after 5 h. The amount of LDH released as 
the result of detergent induced lysis was set to 100% and the amount of signal from 
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Figure A7.  
 
Figure A7. BMDM treated with α-hemolysin release little LDH 8 hpost treatment. 
BMDMs from the experiment shown in Fig. 2.7CD were washed 1 h post toxin 
treatment, after the initial LDH release measurement, and fresh media was added to the 
cells. LDH released into the fresh medium was measured 8 hlater. The amount of LDH 
released as the result of detergent induced lysis was set to 100% and the amount of 
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Figure A8.  
 
Fig A8. Treatment of BMDMs with LLO results in transient caspase-7 activation. 
BMDMs were incubated with 0.25µg/ml LLO for 1 or 2 h continuously, then lysed and 
probed for caspase-7 cleavage. For recovery (recov) samples, cells were incubated with 
0.25µg/ml LLO for 1 h, and then washed and incubated in fresh media without toxin 
for the time noted. Cells were treated with 1µM staurosporine (stp) as a positive control 
for caspase-7 cleavage. Lysates were probed for actin as a loading control. Full length 
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Figure A9.  
 
Figure A9. Caspase-7 deficient cells display slower recovery after LLO intoxication 
compared to BL/6 cells. (A and B)  BMDMs were intoxicated with 0.25µg/ml LLO, after 
which they were incubated directly with 1:50 rhodamine-phalliodin (phall) for 15 min, 
or they were allowed to recover for the indicated time in media without toxin then 
incubated with phall. BMDMs were fixed and assessed for (A) the percentage of total 
cells stained positive for phall and (B) the intensity of phall staining as measured by 
Metamorph software.  N > 200 cells per condition, graphs measure data from 3 
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